fbpx
Wikipedia

Atherosclerosis

February 15, 2024

Not to be confused with Arteriosclerosis.
For the journal, see Atherosclerosis (journal).

Atherosclerosis is a pattern of the disease arteriosclerosis,[8] characterized by development of abnormalities called lesions in walls of arteries. These lesions may lead to narrowing of the arterial walls due to buildup of atheromatous plaques.[9][10] At onset there are usually no symptoms, but if they develop, symptoms generally begin around middle age.[1] In severe cases, it can result in coronary artery disease, stroke, peripheral artery disease, or kidney disorders, depending on which body parts(s) the affected arteries are located in the body.[1]

Atherosclerosis
Other namesArteriosclerotic vascular disease (ASVD)
The progression of atherosclerosis (narrowing exaggerated)
SpecialtyCardiology, angiology
SymptomsNone[1]
ComplicationsCoronary artery disease, stroke, peripheral artery disease, kidney problems[1]
Usual onsetYouth (worsens with age)[2]
CausesAccumulation of saturated fats, smoking, high blood pressure and diabetes
Risk factorsHigh blood pressure, diabetes, smoking, obesity, family history, unhealthy diet (notably trans fat), chronic Vitamin C deficiency[3][4]
PreventionHealthy diet, exercise, not smoking, maintaining a normal weight[5]
MedicationStatins, blood pressure medication, aspirin[6]
Frequency≈100% (>65 years old)[7]

The exact cause of atherosclerosis is unknown and is proposed to be multifactorial.[1] Risk factors include abnormal cholesterol levels, elevated levels of inflammatory biomarkers,[11] high blood pressure, diabetes, smoking (both active and passive smoking), obesity, genetic factors, family history, lifestyle habits, and an unhealthy diet.[4] Plaque is made up of fat, cholesterol, calcium, and other substances found in the blood.[9] The narrowing of arteries limits the flow of oxygen-rich blood to parts of the body.[9] Diagnosis is based upon a physical exam, electrocardiogram, and exercise stress test, among others.[12]

Prevention guidelines include, eating a healthy diet, exercising, not smoking, and maintaining normal body weight.[5] Treatment of established disease may include medications to lower cholesterol such as statins, blood pressure medication, and anticoagulant therapies to reduce the risk of blood clot formation.[6] As the disease state progresses more invasive strategies are applied such as percutaneous coronary intervention, coronary artery bypass graft, or carotid endarterectomy.[6] Genetic factors are also strongly implicated in the disease process; it is not entirely based on lifestyle choices.[13]

Atherosclerosis generally starts when a person is young and worsens with age.[2] Almost all people are affected to some degree by the age of 65.[7] It is the number one cause of death and disability in developed countries.[14][15][16] Though it was first described in 1575,[17] there is evidence suggesting that this disease state is genetically inherent in the broader human population, with its origins tracing back to genetic mutations that may have occurred more than two million years ago during the evolution of hominin ancestors of modern human beings.[18]

Signs and symptoms edit

Atherosclerosis is asymptomatic for decades because the arteries enlarge at all plaque locations, thus there is no effect on blood flow.[19] Even most plaque ruptures do not produce symptoms until enough narrowing or closure of an artery, due to clots, occurs. Signs and symptoms only occur after severe narrowing or closure impedes blood flow to different organs enough to induce symptoms.[20] Most of the time, patients realize that they have the disease only when they experience other cardiovascular disorders such as stroke or heart attack. These symptoms, however, still vary depending on which artery or organ is affected.[21]

Early atherosclerotic processes likely begin in childhood. Fibrous and gelatinous lesions have been observed in the coronary arteries of children.[22] Fatty streaks have been observed in the coronary arteries of juveniles.[22]While coronary artery disease is more prevalent in men than women, atherosclerosis of the cerebral arteries and strokes equally affect both sexes.[23]

Marked narrowing in the coronary arteries, which are responsible for bringing oxygenated blood to the heart, can produce symptoms such as chest pain of angina and shortness of breath, sweating, nausea, dizziness or lightheadedness, breathlessness or palpitations.[21] Abnormal heart rhythms called arrhythmias—the heart beating either too slowly or too quickly—are another consequence of ischemia.[24]

Carotid arteries supply blood to the brain and neck.[24] Marked narrowing of the carotid arteries can present with symptoms such as: a feeling of weakness; being unable to think straight; difficulty speaking; dizziness; difficulty in walking or standing up straight; blurred vision; numbness of the face, arms and legs; severe headache; and loss of consciousness. These symptoms are also related to stroke (death of brain cells). Stroke is caused by marked narrowing or closure of arteries going to the brain; lack of adequate blood supply leads to the death of the cells of the affected tissue.[25]

Peripheral arteries, which supply blood to the legs, arms and pelvis, also experience marked narrowing due to plaque rupture and clots. Symptoms of the narrowing are numbness within the arms or legs, as well as pain. Another significant location for plaque formation is the renal arteries, which supply blood to the kidneys. Plaque occurrence and accumulation lead to decreased kidney blood flow and chronic kidney disease, which, like in all other areas, is typically asymptomatic until late stages.[21]

In 2004, US data indicated that in ~66% of men and ~47% of women, the first symptom of atherosclerotic cardiovascular disease was a heart attack or sudden cardiac death (defined as death within one hour of onset of the symptom).[26]

Case studies have included autopsies of U.S. soldiers killed in World War II and the Korean War. A much-cited report involved the autopsies of 300 U.S. soldiers killed in Korea. Although the average age of the men was 22.1 years, 77.3 percent had "gross evidence of coronary arteriosclerosis".[27]

Risk factors edit

See also: Lipoprotein and Lipoprotein (a)
 
Atherosclerosis and lipoproteins

The atherosclerotic process is not well understood. Atherosclerosis is associated with inflammatory processes in the endothelial cells of the vessel wall associated with retained low-density lipoprotein (LDL) particles.[28][29] This retention may be a cause, an effect, or both, of the underlying inflammatory process.[30]

The presence of the plaque induces the muscle cells of the blood vessel to stretch, compensating for the additional bulk. The endothelial lining then thickens, increasing the separation between the plaque and lumen. The thickening somewhat offsets the narrowing caused by the growth of the plaque, but moreover, it causes the wall to stiffen and become less compliant to stretching with each heartbeat.[31]

Modifiable edit

Nonmodifiable edit

Lesser or uncertain edit

Dietary edit

The relation between dietary fat and atherosclerosis is controversial. The USDA, in its food pyramid, promotes a diet of about 64% carbohydrates from total calories. The American Heart Association, the American Diabetes Association and the National Cholesterol Education Program make similar recommendations. In contrast, Prof Walter Willett (Harvard School of Public Health, PI of the second Nurses' Health Study) recommends much higher levels of fat, especially of monounsaturated and polyunsaturated fat.[52] These dietary recommendations reach a consensus, though, against consumption of trans fats.[citation needed]

The role of eating oxidized fats (rancid fats) in humans is not clear. Rabbits fed rancid fats develop atherosclerosis faster.[53] Rats fed DHA-containing oils experienced marked disruptions to their antioxidant systems, and accumulated significant amounts of phospholipid hydroperoxide in their blood, livers and kidneys.[54]

Rabbits fed atherogenic diets containing various oils were found to undergo the most oxidative susceptibility of LDL via polyunsaturated oils.[55] In another study, rabbits fed heated soybean oil "grossly induced atherosclerosis and marked liver damage were histologically and clinically demonstrated."[56] However, Fred Kummerow claims that it is not dietary cholesterol, but oxysterols, or oxidized cholesterols, from fried foods and smoking, that are the culprit.[57]

Rancid fats and oils taste very unpleasant in even small amounts, so people avoid eating them.[58] It is very difficult to measure or estimate the actual human consumption of these substances.[59] Highly unsaturated omega-3 rich oils such as fish oil, when being sold in pill form, can hide the taste of oxidized or rancid fat that might be present. In the US, the health food industry's dietary supplements are self-regulated and outside of FDA regulations.[60] To properly protect unsaturated fats from oxidation, it is best to keep them cool and in oxygen-free environments.[61]

Pathophysiology edit

Atherogenesis is the developmental process of atheromatous plaques. It is characterized by a remodeling of arteries leading to subendothelial accumulation of fatty substances called plaques. The buildup of an atheromatous plaque is a slow process, developed over a period of several years through a complex series of cellular events occurring within the arterial wall and in response to a variety of local vascular circulating factors. One recent hypothesis suggests that, for unknown reasons, leukocytes, such as monocytes or basophils, begin to attack the endothelium of the artery lumen in cardiac muscle. The ensuing inflammation leads to the formation of atheromatous plaques in the arterial tunica intima, a region of the vessel wall located between the endothelium and the tunica media. The bulk of these lesions is made of excess fat, collagen, and elastin. At first, as the plaques grow, only wall thickening occurs without any narrowing. Stenosis is a late event, which may never occur and is often the result of repeated plaque rupture and healing responses, not just the atherosclerotic process by itself.[62]

Cellular edit

 
Micrograph of an artery that supplies the heart showing significant atherosclerosis and marked luminal narrowing. Tissue has been stained using Masson's trichrome.

Early atherogenesis is characterized by the adherence of blood circulating monocytes (a type of white blood cell) to the vascular bed lining, the endothelium, then by their migration to the sub-endothelial space, and further activation into monocyte-derived macrophages.[63] The primary documented driver of this process is oxidized lipoprotein particles within the wall, beneath the endothelial cells, though upper normal or elevated concentrations of blood glucose also plays a major role and not all factors are fully understood. Fatty streaks may appear and disappear.[citation needed]

Low-density lipoprotein (LDL) particles in blood plasma invade the endothelium and become oxidized, creating risk of cardiovascular disease. A complex set of biochemical reactions regulates the oxidation of LDL, involving enzymes (such as Lp-LpA2) and free radicals in the endothelium.[64]

Initial damage to the endothelium results in an inflammatory response. Monocytes enter the artery wall from the bloodstream, with platelets adhering to the area of insult. This may be promoted by redox signaling induction of factors such as VCAM-1, which recruit circulating monocytes, and M-CSF, which is selectively required for the differentiation of monocytes to macrophages. The monocytes differentiate into macrophages, which proliferate locally,[65] ingest oxidized LDL, slowly turning into large "foam cells" – so-called because of their changed appearance resulting from the numerous internal cytoplasmic vesicles and resulting high lipid content. Under the microscope, the lesion now appears as a fatty streak. Foam cells eventually die and further propagate the inflammatory process.[citation needed]

In addition to these cellular activities, there is also smooth muscle proliferation and migration from the tunica media into the intima in response to cytokines secreted by damaged endothelial cells. This causes the formation of a fibrous capsule covering the fatty streak. Intact endothelium can prevent this smooth muscle proliferation by releasing nitric oxide.[citation needed]

Calcification and lipids edit

Calcification forms among vascular smooth muscle cells of the surrounding muscular layer, specifically in the muscle cells adjacent to atheromas and on the surface of atheroma plaques and tissue.[66] In time, as cells die, this leads to extracellular calcium deposits between the muscular wall and outer portion of the atheromatous plaques. With the atheromatous plaque interfering with the regulation of the calcium deposition, it accumulates and crystallizes. A similar form of intramural calcification, presenting the picture of an early phase of arteriosclerosis, appears to be induced by many drugs that have an antiproliferative mechanism of action (Rainer Liedtke 2008).[citation needed]

Cholesterol is delivered into the vessel wall by cholesterol-containing low-density lipoprotein (LDL) particles. To attract and stimulate macrophages, the cholesterol must be released from the LDL particles and oxidized, a key step in the ongoing inflammatory process. The process is worsened if it is insufficient high-density lipoprotein (HDL), the lipoprotein particle that removes cholesterol from tissues and carries it back to the liver.[64]

The foam cells and platelets encourage the migration and proliferation of smooth muscle cells, which in turn ingest lipids, become replaced by collagen, and transform into foam cells themselves. A protective fibrous cap normally forms between the fatty deposits and the artery lining (the intima).[citation needed]

These capped fatty deposits (now called 'atheromas') produce enzymes that cause the artery to enlarge over time. As long as the artery enlarges sufficiently to compensate for the extra thickness of the atheroma, then no narrowing ("stenosis") of the opening ("lumen") occurs. The artery becomes expanded with an egg-shaped cross-section, still with a circular opening. If the enlargement is beyond proportion to the atheroma thickness, then an aneurysm is created.[67]

Visible features edit

 
Severe atherosclerosis of the aorta. Autopsy specimen.

Although arteries are not typically studied microscopically, two plaque types can be distinguished:[68]

  1. The fibro-lipid (fibro-fatty) plaque is characterized by an accumulation of lipid-laden cells underneath the intima of the arteries, typically without narrowing the lumen due to compensatory expansion of the bounding muscular layer of the artery wall. Beneath the endothelium, there is a "fibrous cap" covering the atheromatous "core" of the plaque. The core consists of lipid-laden cells (macrophages and smooth muscle cells) with elevated tissue cholesterol and cholesterol ester content, fibrin, proteoglycans, collagen, elastin, and cellular debris. In advanced plaques, the central core of the plaque usually contains extracellular cholesterol deposits (released from dead cells), which form areas of cholesterol crystals with empty, needle-like clefts. At the periphery of the plaque are younger "foamy" cells and capillaries. These plaques usually produce the most damage to the individual when they rupture. Cholesterol crystals may also play a role.[69]
  2. The fibrous plaque is also localized under the intima, within the wall of the artery resulting in thickening and expansion of the wall and, sometimes, spotty localized narrowing of the lumen with some atrophy of the muscular layer. The fibrous plaque contains collagen fibers (eosinophilic), precipitates of calcium (hematoxylinophilic), and rarely, lipid-laden cells.[citation needed]

In effect, the muscular portion of the artery wall forms small aneurysms just large enough to hold the atheroma that are present. The muscular portion of artery walls usually remains strong, even after they have remodeled to compensate for the atheromatous plaques.[citation needed]

However, atheromas within the vessel wall are soft and fragile with little elasticity. Arteries constantly expand and contract with each heartbeat, i.e., the pulse. In addition, the calcification deposits between the outer portion of the atheroma and the muscular wall, as they progress, lead to a loss of elasticity and stiffening of the artery as a whole.[citation needed]

The calcification deposits,[70] after they have become sufficiently advanced, are partially visible on coronary artery computed tomography or electron beam tomography (EBT) as rings of increased radiographic density, forming halos around the outer edges of the atheromatous plaques, within the artery wall. On CT, >130 units on the Hounsfield scale (some argue for 90 units) has been the radiographic density usually accepted as clearly representing tissue calcification within arteries. These deposits demonstrate unequivocal evidence of the disease, relatively advanced, even though the lumen of the artery is often still normal by angiography.[citation needed]

Rupture and stenosis edit

 
Progression of atherosclerosis to late complications

Although the disease process tends to be slowly progressive over decades, it usually remains asymptomatic until an atheroma ulcerates, which leads to immediate blood clotting at the site of the atheroma ulcer. This triggers a cascade of events that leads to clot enlargement, which may quickly obstruct the flow of blood. A complete blockage leads to ischemia of the myocardial (heart) muscle and damage. This process is the myocardial infarction or "heart attack".[71]

If the heart attack is not fatal, fibrous organization of the clot within the lumen ensues, covering the rupture but also producing stenosis or closure of the lumen, or over time and after repeated ruptures, resulting in a persistent, usually localized stenosis or blockage of the artery lumen. Stenoses can be slowly progressive, whereas plaque ulceration is a sudden event that occurs specifically in atheromas with thinner/weaker fibrous caps that have become "unstable".[71]

Repeated plaque ruptures, ones not resulting in total lumen closure, combined with the clot patch over the rupture and healing response to stabilize the clot is the process that produces most stenoses over time. The stenotic areas tend to become more stable despite increased flow velocities at these narrowings. Most major blood-flow-stopping events occur at large plaques, which, before their rupture, produced very little if any stenosis.[citation needed]

From clinical trials, 20% is the average stenosis at plaques that subsequently rupture with resulting complete artery closure. Most severe clinical events do not occur at plaques that produce high-grade stenosis. From clinical trials, only 14% of heart attacks occur from artery closure at plaques producing a 75% or greater stenosis before the vessel closing.[citation needed]

If the fibrous cap separating a soft atheroma from the bloodstream within the artery ruptures, tissue fragments are exposed and released. These tissue fragments are very clot-promoting, containing collagen and tissue factor; they activate platelets and activate the system of coagulation. The result is the formation of a thrombus (blood clot) overlying the atheroma, which obstructs blood flow acutely. With the obstruction of blood flow, downstream tissues are starved of oxygen and nutrients. If this is the myocardium (heart muscle) angina (cardiac chest pain) or myocardial infarction (heart attack) develops.[citation needed]

Accelerated growth of plaques edit

The distribution of atherosclerotic plaques in a part of arterial endothelium is inhomogeneous. The multiple and focal development of atherosclerotic changes is similar to that in the development of amyloid plaques in the brain and that of age spots on the skin. Misrepair-accumulation aging theory suggests that misrepair mechanisms[72][73] play an important role in the focal development of atherosclerosis.[74] Development of a plaque is a result of repair of injured endothelium. Because of the infusion of lipids into sub-endothelium, the repair has to end up with altered remodeling of local endothelium. This is the manifestation of a misrepair. Important is this altered remodeling makes the local endothelium have increased fragility to damage and have reduced repair efficiency. As a consequence, this part of endothelium has an increased risk factor of being injured and improperly repaired. Thus, the accumulation of misrepairs of endothelium is focalized and self-accelerating. In this way, the growing of a plaque is also self-accelerating. Within a part of the arterial wall, the oldest plaque is always the biggest, and is the most dangerous one to cause blockage of a local artery.[citation needed]

Components edit

The plaque is divided into three distinct components:

  1. The atheroma ("lump of gruel", from Greek ἀθήρα (athera) 'gruel'), which is the nodular accumulation of a soft, flaky, yellowish material at the center of large plaques, composed of macrophages nearest the lumen of the artery[citation needed]
  2. Underlying areas of cholesterol crystals[citation needed]
  3. Calcification at the outer base of older or more advanced lesions. Atherosclerotic lesions, or atherosclerotic plaques, are separated into two broad categories: Stable and unstable (also called vulnerable).[75] The pathobiology of atherosclerotic lesions is very complicated, but generally, stable atherosclerotic plaques, which tend to be asymptomatic, are rich in extracellular matrix and smooth muscle cells. On the other hand, unstable plaques are rich in macrophages and foam cells, and the extracellular matrix separating the lesion from the arterial lumen (also known as the fibrous cap) is usually weak and prone to rupture.[76] Ruptures of the fibrous cap expose thrombogenic material, such as collagen,[77] to the circulation and eventually induce thrombus formation in the lumen. Upon formation, intraluminal thrombi can occlude arteries outright (e.g., coronary occlusion), but more often they detach, move into the circulation, and eventually occlude smaller downstream branches causing thromboembolism.[citation needed]

Apart from thromboembolism, chronically expanding atherosclerotic lesions can cause complete closure of the lumen. Chronically expanding lesions are often asymptomatic until lumen stenosis is so severe (usually over 80%) that blood supply to downstream tissue(s) is insufficient, resulting in ischemia. These complications of advanced atherosclerosis are chronic, slowly progressive, and cumulative. Most commonly, soft plaque suddenly ruptures (see vulnerable plaque), causing the formation of a thrombus that will rapidly slow or stop blood flow, leading to the death of the tissues fed by the artery in approximately five minutes. This event is called an infarction.[citation needed]

Diagnosis edit

 
CT image of atherosclerosis of the abdominal aorta. Woman of 70 years old with hypertension and dyslipidemia.
 
Microphotography of arterial wall with calcified (violet color) atherosclerotic plaque (hematoxylin and eosin stain)

Areas of severe narrowing, stenosis, detectable by angiography, and to a lesser extent "stress testing" have long been the focus of human diagnostic techniques for cardiovascular disease, in general. However, these methods focus on detecting only severe narrowing, not the underlying atherosclerosis disease.[78] As demonstrated by human clinical studies, most severe events occur in locations with heavy plaque, yet little or no lumen narrowing present before debilitating events suddenly occur. Plaque rupture can lead to artery lumen occlusion within seconds to minutes, and potential permanent debility, and sometimes sudden death.[citation needed]

Plaques that have ruptured are called complicated lesions. The extracellular matrix of the lesion breaks, usually at the shoulder of the fibrous cap that separates the lesion from the arterial lumen, where the exposed thrombogenic components of the plaque, mainly collagen, will trigger thrombus formation. The thrombus then travels downstream to other blood vessels, where the blood clot may partially or completely block blood flow. If the blood flow is completely blocked, cell deaths occur due to the lack of oxygen supply to nearby cells, resulting in necrosis.[79] The narrowing or obstruction of blood flow can occur in any artery within the body. Obstruction of arteries supplying the heart muscle results in a heart attack, while the obstruction of arteries supplying the brain results in an ischaemic stroke.[citation needed]

 
Doppler ultrasound of right internal carotid artery with calcified and non-calcified plaques showing less than 70% stenosis

Lumen stenosis that is greater than 75% was considered the hallmark of clinically significant disease in the past because recurring episodes of angina and abnormalities in stress tests are only detectable at that particular severity of stenosis. However, clinical trials have shown that only about 14% of clinically debilitating events occur at sites with more than 75% stenosis. The majority of cardiovascular events that involve sudden rupture of the atheroma plaque do not display any evident narrowing of the lumen. Thus, greater attention has been focused on "vulnerable plaque" from the late 1990s onwards.[80]

Besides the traditional diagnostic methods such as angiography and stress-testing, other detection techniques have been developed in the past decades for earlier detection of atherosclerotic disease. Some of the detection approaches include anatomical detection and physiologic measurement.[citation needed]

Examples of anatomical detection methods include coronary calcium scoring by CT, carotid IMT (intimal media thickness) measurement by ultrasound, and intravascular ultrasound (IVUS). Examples of physiologic measurement methods include lipoprotein subclass analysis, HbA1c, hs-CRP, and homocysteine.[citation needed] Both anatomic and physiologic methods allow early detection before symptoms show up, disease staging, and tracking of disease progression. Anatomic methods are more expensive and some of them are invasive in nature, such as IVUS. On the other hand, physiologic methods are often less expensive and safer. But they do not quantify the current state of the disease or directly track progression. In recent years, developments in nuclear imaging techniques such as PET and SPECT have provided ways of estimating the severity of atherosclerotic plaques.[78]

Prevention edit

Up to 90% of cardiovascular disease may be preventable if established risk factors are avoided.[81][82] Medical management of atherosclerosis first involves modification to risk factors–for example, via smoking cessation and diet restrictions. Prevention then is generally by eating a healthy diet, exercising, not smoking, and maintaining a normal weight.[5]

Diet edit

Changes in diet may help prevent the development of atherosclerosis. Tentative evidence suggests that a diet containing dairy products has no effect on or decreases the risk of cardiovascular disease.[83][84]

A diet high in fruits and vegetables decreases the risk of cardiovascular disease and death.[85] Evidence suggests that the Mediterranean diet may improve cardiovascular results.[86] There is also evidence that a Mediterranean diet may be better than a low-fat diet in bringing about long-term changes to cardiovascular risk factors (e.g., lower cholesterol level and blood pressure).[87]

Exercise edit

A controlled exercise program combats atherosclerosis by improving circulation and functionality of the vessels. Exercise is also used to manage weight in patients who are obese, lower blood pressure, and decrease cholesterol. Often lifestyle modification is combined with medication therapy. For example, statins help to lower cholesterol. Antiplatelet medications like aspirin help to prevent clots, and a variety of antihypertensive medications are routinely used to control blood pressure. If the combined efforts of risk factor modification and medication therapy are not sufficient to control symptoms or fight imminent threats of ischemic events, a physician may resort to interventional or surgical procedures to correct the obstruction.[88]

Treatment edit

Treatment of established disease may include medications to lower cholesterol such as statins, blood pressure medication, or medications that decrease clotting, such as aspirin.[6] A number of procedures may also be carried out such as percutaneous coronary intervention, coronary artery bypass graft, or carotid endarterectomy.[6]

Medical treatments often focus on alleviating symptoms. However measures which focus on decreasing underlying atherosclerosis—as opposed to simply treating symptoms—are more effective.[89] Non-pharmaceutical means are usually the first method of treatment, such as stopping smoking and practicing regular exercise.[90][91] If these methods do not work, medicines are usually the next step in treating cardiovascular diseases and, with improvements, have increasingly become the most effective method over the long term.[92]

The key to the more effective approaches is to combine multiple different treatment strategies.[93] In addition, for those approaches, such as lipoprotein transport behaviors, which have been shown to produce the most success, adopting more aggressive combination treatment strategies taken on a daily basis and indefinitely has generally produced better results, both before and especially after people are symptomatic.[89]

Statins edit

The group of medications referred to as statins are widely prescribed for treating atherosclerosis. They have shown benefit in reducing cardiovascular disease and mortality in those with high cholesterol with few side effects.[94] Secondary prevention therapy, which includes high-intensity statins and aspirin, is recommended by multi-society guidelines for all patients with history of ASCVD (atherosclerotic cardiovascular disease) to prevent recurrence of coronary artery disease, ischemic stroke, or peripheral arterial disease.[95][96] However, prescription of and adherence to these guideline-concordant therapies is lacking, particularly among young patients and women.[97][98]

Statins work by inhibiting HMG-CoA (hydroxymethylglutaryl-coenzyme A) reductase, a hepatic rate-limiting enzyme in cholesterol's biochemical production pathway. By inhibiting this rate-limiting enzyme, the body is unable to produce cholesterol endogenously, therefore reducing serum LDL-cholesterol. This reduced endogenous cholesterol production triggers the body to then pull cholesterol from other cellular sources, enhancing serum HDL-cholesterol.[citation needed] These data are primarily in middle-age men and the conclusions are less clear for women and people over the age of 70.[99]

Surgery edit

When atherosclerosis has become severe and caused irreversible ischemia, such as tissue loss in the case of peripheral artery disease, surgery may be indicated. Vascular bypass surgery can re-establish flow around the diseased segment of artery, and angioplasty with or without stenting can reopen narrowed arteries and improve blood flow. Coronary artery bypass grafting without manipulation of the ascending aorta has demonstrated reduced rates of postoperative stroke and mortality compared to traditional on-pump coronary revascularization.[100]

Other edit

There is evidence that some anticoagulants, particularly warfarin, which inhibit clot formation by interfering with Vitamin K metabolism, may actually promote arterial calcification in the long term despite reducing clot formation in the short term.[101][102][103][104][excessive citations] Also, small molecules such as 3-hydroxybenzaldehyde and protocatechuic aldehyde have shown vasculoprotective effects to reduce risk of atherosclerosis.[105][106]

Epidemiology edit

Cardiovascular disease, which is predominantly the clinical manifestation of atherosclerosis, is one of the leading causes of death worldwide.[107]

Almost all children older than age 10 in developed countries have aortic fatty streaks, with coronary fatty streaks beginning in adolescence.[108][109][110]

In 1953, a study was published which examined the results of 300 autopsies performed on U.S. soldiers who had died in the Korean War. Despite the average age of the soldiers being just 22 years old, 77% of them had visible signs of coronary atherosclerosis. This study showed that heart disease could affect people at a younger age and was not just a problem for older individuals.[111][112][113]

In 1992, a report had shown that microscopic fatty streaks were seen in the left anterior descending artery in over 50% of children aged 10–14 and 8% had even more advanced lesions with more accumulations of extracellular lipid.[114]

In a 2005 report of a study done between 1985 and 1995, it was found that around 87% of aortas and 30% of coronary arteries in age group 5–14 years had fatty streaks which increased with age.[115]

Etymology edit

The following terms are similar, yet distinct, in both spelling and meaning, and can be easily confused: arteriosclerosis, arteriolosclerosis, and atherosclerosis. Arteriosclerosis is a general term describing any hardening (and loss of elasticity) of medium or large arteries (from Greek ἀρτηρία (artēria) 'artery', and σκλήρωσις (sklerosis) 'hardening'); arteriolosclerosis is any hardening (and loss of elasticity) of arterioles (small arteries); atherosclerosis is a hardening of an artery specifically due to an atheromatous plaque (from Ancient Greek ἀθήρα (athḗra) 'gruel'). The term atherogenic is used for substances or processes that cause formation of atheroma.[116]

Economics edit

In 2011, coronary atherosclerosis was one of the top ten most expensive conditions seen during inpatient hospitalizations in the US, with aggregate inpatient hospital costs of $10.4 billion.[117]

Research edit

Lipids edit

An indication of the role of high-density lipoprotein (HDL) on atherosclerosis has been with the rare Apo-A1 Milano human genetic variant of this HDL protein. A small short-term trial using bacterial synthesized human Apo-A1 Milano HDL in people with unstable angina produced a fairly dramatic reduction in measured coronary plaque volume in only six weeks vs. the usual increase in plaque volume in those randomized to placebo. The trial was published in JAMA in early 2006.[citation needed] Ongoing work starting in the 1990s may lead to human clinical trials—probably by about 2008.[needs update] These may use synthesized Apo-A1 Milano HDL directly, or they may use gene-transfer methods to pass the ability to synthesize the Apo-A1 Milano HDLipoprotein.[citation needed]

Methods to increase HDL particle concentrations, which in some animal studies largely reverses and removes atheromas, are being developed and researched.[citation needed] However, increasing HDL by any means is not necessarily helpful. For example, the drug torcetrapib is the most effective agent currently known for raising HDL (by up to 60%). However, in clinical trials, it also raised deaths by 60%. All studies regarding this drug were halted in December 2006.[118]

The actions of macrophages drive atherosclerotic plaque progression. Immunomodulation of atherosclerosis is the term for techniques that modulate immune system function to suppress this macrophage action.[119]

Involvement of lipid peroxidation chain reaction in atherogenesis[120] triggered research on the protective role of the heavy isotope (deuterated) polyunsaturated fatty acids (D-PUFAs) that are less prone to oxidation than ordinary PUFAs (H-PUFAs). PUFAs are essential nutrients – they are involved in metabolism in that very form as they are consumed with food. In transgenic mice, that are a model for human-like lipoprotein metabolism, adding D-PUFAs to diet indeed reduced body weight gain, improved cholesterol handling and reduced atherosclerotic damage to the aorta.[121][122]

miRNA edit

MicroRNAs (miRNAs) have complementary sequences in the 3' UTR and 5' UTR of target mRNAs of protein-coding genes, and cause mRNA cleavage or repression of translational machinery. In diseased vascular vessels, miRNAs are dysregulated and highly expressed. miR-33 is found in cardiovascular diseases.[123] It is involved in atherosclerotic initiation and progression including lipid metabolism, insulin signaling and glucose homeostatis, cell type progression and proliferation, and myeloid cell differentiation. It was found in rodents that the inhibition of miR-33 will raise HDL level and the expression of miR-33 is down-regulated in humans with atherosclerotic plaques.[124][125][126]

miR-33a and miR-33b are located on intron 16 of human sterol regulatory element-binding protein 2 (SREBP2) gene on chromosome 22 and intron 17 of SREBP1 gene on chromosome 17.[127] miR-33a/b regulates cholesterol/lipid homeostatis by binding in the 3'UTRs of genes involved in cholesterol transport such as ATP binding cassette (ABC) transporters and enhance or represses its expression. Study have shown that ABCA1 mediates transport of cholesterol from peripheral tissues to Apolipoprotein-1 and it is also important in the reverse cholesterol transport pathway, where cholesterol is delivered from peripheral tissue to the liver, where it can be excreted into bile or converted to bile acids prior to excretion.[123] Therefore, we know that ABCA1 plays an important role in preventing cholesterol accumulation in macrophages. By enhancing miR-33 function, the level of ABCA1 is decreased, leading to decrease cellular cholesterol efflux to apoA-1. On the other hand, by inhibiting miR-33 function, the level of ABCA1 is increased and increases the cholesterol efflux to apoA-1. Suppression of miR-33 will lead to less cellular cholesterol and higher plasma HDL level through the regulation of ABCA1 expression.[128]

The sugar, cyclodextrin, removed cholesterol that had built up in the arteries of mice fed a high-fat diet.[129]

DNA damage edit

Aging is the most important risk factor for cardiovascular problems. The causative basis by which aging mediates its impact, independently of other recognized risk factors, remains to be determined. Evidence has been reviewed for a key role of DNA damage in vascular aging.[130][131][132]8-oxoG, a common type of oxidative damage in DNA, is found to accumulate in plaque vascular smooth muscle cells, macrophages and endothelial cells,[133] thus linking DNA damage to plaque formation. DNA strand breaks also increased in atherosclerotic plaques.[133] Werner syndrome (WS) is a premature aging condition in humans.[134] WS is caused by a genetic defect in a RecQ helicase that is employed in several repair processes that remove damages from DNA. WS patients develop a considerable burden of atherosclerotic plaques in their coronary arteries and aorta: calcification of the aortic valve is also frequently observed.[131] These findings link excessive unrepaired DNA damage to premature aging and early atherosclerotic plaque development (see DNA damage theory of aging).[citation needed]

Microorganisms edit

The microbiota – all the microorganisms in the body, can contribute to atherosclerosis in many ways: modulation of the immune system, changes in metabolism, processing of nutrients and production of certain metabolites that can get into blood circulation.[135] One such metabolite, produced by gut bacteria, is trimethylamine N-oxide (TMAO). Its levels have been associated with atherosclerosis in human studies and animal research suggest that there can be a causal relation. An association between the bacterial genes encoding trimethylamine lyases — the enzymes involved in TMAO generation — and atherosclerosis has been noted.[136][135]

Vascular smooth muscle cells edit

Vascular smooth muscle cells play a key role in atherogenesis and were historically considered to be beneficial for plaque stability by forming a protective fibrous cap and synthesising strength-giving extracellular matrix components.[137][138] However, in addition to the fibrous cap, vascular smooth muscle cells also give rise to many of the cell types found within the plaque core and can modulate their phenotype to both promote and reduce plaque stability.[137][139][140][141] Vascular smooth muscle cells exhibit pronounced plasticity within atherosclerotic plaque and can modify their gene expression profile to resemble various other cell types, including macrophages, myofibroblasts, mesenchymal stem cells and osteochondrocytes.[142][143][137] Importantly, genetic lineage‐tracing experiments have unequivocally shown that 40-90% of plaque-resident cells are vascular smooth muscle cell derived,[140][141] therefore, it is important to research the role of vascular smooth muscle cells in atherosclerosis to identify new therapeutic targets.

References edit

  1. ^ a b c d e "What Are the Signs and Symptoms of Atherosclerosis? - NHLBI, NIH". www.nhlbi.nih.gov. 22 June 2016. Retrieved 5 November 2017.
  2. ^ a b "What Causes Atherosclerosis? - NHLBI, NIH". www.nhlbi.nih.gov. 22 June 2016. Retrieved 6 November 2017.
  3. ^ "New Concept of Heart Disease Posits Vitamin C Deficiency as Culprit". DAIC (Diagnostic and Interventional Cardiology). 27 April 2015. Retrieved 2022-02-06.
  4. ^ a b "Who Is at Risk for Atherosclerosis?". www.nhlbi.nih.gov. 22 June 2016. Retrieved 5 November 2017.
  5. ^ a b c "How Can Atherosclerosis Be Prevented or Delayed? - NHLBI, NIH". www.nhlbi.nih.gov. 22 June 2016. Retrieved 6 November 2017.
  6. ^ a b c d e "How Is Atherosclerosis Treated? - NHLBI, NIH". www.nhlbi.nih.gov. 22 June 2016. Retrieved 6 November 2017.
  7. ^ a b Aronow WS, Fleg JL, Rich MW (2013). Tresch and Aronow's Cardiovascular Disease in the Elderly, Fifth Edition. CRC Press. p. 171. ISBN 978-1-84214-544-9.
  8. ^ "Arteriosclerosis / atherosclerosis - Symptoms and causes". Mayo Clinic. Retrieved 2021-05-06.
  9. ^ a b c "What Is Atherosclerosis? - NHLBI, NIH". www.nhlbi.nih.gov. 22 June 2016. Retrieved 6 November 2017.
  10. ^ Tsukahara, Tamotsu; Tsukahara, Ryoko; Haniu, Hisao; Matsuda, Yoshikazu; Murakami-Murofushi, Kimiko (2015-09-05). "Cyclic phosphatidic acid inhibits the secretion of vascular endothelial growth factor from diabetic human coronary artery endothelial cells through peroxisome proliferator-activated receptor gamma". Molecular and Cellular Endocrinology. 412: 320–329. doi:10.1016/j.mce.2015.05.021. hdl:10069/35888. ISSN 0303-7207. PMID 26007326. S2CID 10454566.
  11. ^ Lind L (August 2003). "Circulating markers of inflammation and atherosclerosis". Atherosclerosis. 169 (2): 203–214. doi:10.1016/s0021-9150(03)00012-1. PMID 12921971.
  12. ^ "How Is Atherosclerosis Diagnosed? - NHLBI, NIH". www.nhlbi.nih.gov. 22 June 2016. Retrieved 6 November 2017.
  13. ^ Information (US), National Center for Biotechnology (1998), "Atherosclerosis", Genes and Disease [Internet], National Center for Biotechnology Information (US), retrieved 2023-11-21
  14. ^ Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. (December 2020). "Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study". Journal of the American College of Cardiology. 76 (25): 2982–3021. doi:10.1016/j.jacc.2020.11.010. PMC 7755038. PMID 33309175.
  15. ^ Song P, Fang Z, Wang H, Cai Y, Rahimi K, Zhu Y, et al. (May 2020). "Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study". The Lancet. Global Health. 8 (5): e721–e729. doi:10.1016/S2214-109X(20)30117-0. hdl:10044/1/78967. PMID 32353319. S2CID 218474949.
  16. ^ Topol EJ, Califf RM (2007). Textbook of Cardiovascular Medicine. Lippincott Williams & Wilkins. p. 2. ISBN 978-0-7817-7012-5.
  17. ^ Shor A (2008). Chlamydia Atherosclerosis Lesion: Discovery, Diagnosis and Treatment. Springer Science & Business Media. p. 8. ISBN 978-1-84628-810-4.
  18. ^ "Evolutionary gene loss may help explain why only humans are prone to heart attacks". ScienceDaily. Retrieved 2023-11-21.
  19. ^ Ross R (April 1993). "The pathogenesis of atherosclerosis: a perspective for the 1990s". Nature. 362 (6423): 801–9. Bibcode:1993Natur.362..801R. doi:10.1038/362801a0. PMID 8479518. S2CID 4282916.
  20. ^ Atherosclerosis. Harvard Health Publications Harvard Health Publications. Health Topics A – Z, (2011)
  21. ^ a b c "Atherosclerosis". National Heart, Lung and Blood Institute. 2011.
  22. ^ a b Velican D, Velican C (June 1979). "Study of fibrous plaques occurring in the coronary arteries of children". Atherosclerosis. 33 (2): 201–205. doi:10.1016/0021-9150(79)90117-5. PMID 475879.
  23. ^ Flora GC, Baker AB, Loewenson RB, Klassen AC (November 1968). "A comparative study of cerebral atherosclerosis in males and females". Circulation. 38 (5): 859–69. doi:10.1161/01.CIR.38.5.859. PMID 5697685.
  24. ^ a b Arrhythmia. Heart and Stroke Foundation. . Archived from the original on 2014-02-03. Retrieved 2014-01-31. (2011)
  25. ^ Sims NR, Muyderman H (January 2010). "Mitochondria, oxidative metabolism and cell death in stroke" (PDF). Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802 (1): 80–91. doi:10.1016/j.bbadis.2009.09.003. PMID 19751827.
  26. ^ Roquer, J.; Ois, Angel (2010), Preedy, Victor R.; Watson, Ronald R. (eds.), "Atherosclerotic Burden and Mortality", Handbook of Disease Burdens and Quality of Life Measures, New York, NY: Springer, pp. 899–918, doi:10.1007/978-0-387-78665-0_51, ISBN 978-0-387-78665-0, retrieved 2023-11-10
  27. ^ Enos WF, Holmes RH, Beyer J (1953). "Coronary disease among United States soldiers killed in action in Korea: Preliminary Report". JAMA. 152 (12): 1090–93. doi:10.1001/jama.1953.03690120006002. PMID 13052433. The average age was calculated from the ages of 200 of the soldiers. No age was recorded in nearly 100 of the men.
  28. ^ Li X, Fang P, Li Y, Kuo YM, Andrews AJ, Nanayakkara G, Johnson C, Fu H, Shan H, Du F, Hoffman NE, Yu D, Eguchi S, Madesh M, Koch WJ, Sun J, Jiang X, Wang H, Yang X (June 2016). "Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation". Arteriosclerosis, Thrombosis, and Vascular Biology. 36 (6): 1090–100. doi:10.1161/ATVBAHA.115.306964. PMC 4882253. PMID 27127201.
  29. ^ Botts SR, Fish JE, Howe KL (December 2021). "Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment". Frontiers in Pharmacology. 12: 787541. doi:10.3389/fphar.2021.787541. PMC 8727904. PMID 35002720.
  30. ^ Williams KJ, Tabas I (May 1995). "The response-to-retention hypothesis of early atherogenesis". Arteriosclerosis, Thrombosis, and Vascular Biology. 15 (5): 551–61. doi:10.1161/01.ATV.15.5.551. PMC 2924812. PMID 7749869.
  31. ^ Aviram M, Fuhrman B (November 1998). "LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants". Molecular and Cellular Biochemistry. 188 (1–2): 149–59. doi:10.1023/A:1006841011201. PMID 9823020. S2CID 12222110.
  32. ^ a b c d e f g h i j k l m n o p q "Atherosclerosis | NHLBI, NIH". 24 March 2022.
  33. ^ Campbell LA, Rosenfeld ME (July 2015). "Infection and Atherosclerosis Development". Arch Med Res. 46 (5): 339–50. doi:10.1016/j.arcmed.2015.05.006. PMC 4524506. PMID 26004263.
  34. ^ Sinha A, Feinstein MJ (March 2019). "Coronary Artery Disease Manifestations in HIV: What, How, and Why". The Canadian Journal of Cardiology. 35 (3): 270–279. doi:10.1016/j.cjca.2018.11.029. PMC 9532012. PMID 30825949. S2CID 73469601.
  35. ^ Enas EA, Kuruvila A, Khanna P, Pitchumoni CS, Mohan V (October 2013). "Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes". The Indian Journal of Medical Research. 138 (4): 461–91. PMC 3868060. PMID 24434254.
  36. ^ Indian Heart Association Why South Asians Facts Web. 30 April 2015. http://indianheartassociation.org/why-indians-why-south-asians/overview/
  37. ^ Tyrrell DJ, Blin MB, Song J, Wood SC, Zhang M, Beard DA, Goldstein DR (January 2020). "Age-Associated Mitochondrial Dysfunction Accelerates Atherogenesis". Circulation Research. 126 (3): 298–314. doi:10.1161/CIRCRESAHA.119.315644. PMC 7006722. PMID 31818196.
  38. ^ Velican C, Velican D (March 1985). "Differences in the pattern of atherosclerotic involvement between non-branched regions and adjacent branching points of human coronary arteries". Atherosclerosis. 54 (3): 333–342. doi:10.1016/0021-9150(85)90126-1. PMID 3994786.
  39. ^ Borissoff JI, Spronk HM, Heeneman S, ten Cate H (June 2009). "Is thrombin a key player in the 'coagulation-atherogenesis' maze?". Cardiovascular Research. 82 (3): 392–403. doi:10.1093/cvr/cvp066. PMID 19228706.
  40. ^ Borissoff JI, Heeneman S, Kilinç E, Kassák P, Van Oerle R, Winckers K, Govers-Riemslag JW, Hamulyák K, Hackeng TM, Daemen MJ, ten Cate H, Spronk HM (August 2010). "Early atherosclerosis exhibits an enhanced procoagulant state". Circulation. 122 (8): 821–30. doi:10.1161/CIRCULATIONAHA.109.907121. PMID 20697022.
  41. ^ Borissoff JI, Spronk HM, ten Cate H (May 2011). "The hemostatic system as a modulator of atherosclerosis". The New England Journal of Medicine. 364 (18): 1746–60. doi:10.1056/NEJMra1011670. PMID 21542745.
  42. ^ Food and nutrition board, institute of medicine of the national academies (2005). Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). National Academies Press. pp. 481–484. doi:10.17226/10490. ISBN 978-0-309-08525-0.
  43. ^ Mozaffarian D, Rimm EB, Herrington DM (November 2004). "Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women". The American Journal of Clinical Nutrition. 80 (5): 1175–84. doi:10.1093/ajcn/80.5.1175. PMC 1270002. PMID 15531663.
  44. ^ Bhatt DL, Topol EJ (July 2002). "Need to test the arterial inflammation hypothesis". Circulation. 106 (1): 136–40. doi:10.1161/01.CIR.0000021112.29409.A2. PMID 12093783.
  45. ^ Griffin M, Frazer A, Johnson A, Collins P, Owens D, Tomkin GH (June 1998). "Cellular cholesterol synthesis--the relationship to post-prandial glucose and insulin following weight loss". Atherosclerosis. 138 (2): 313–8. doi:10.1016/S0021-9150(98)00036-7. PMID 9690914.
  46. ^ King CR, Knutson KL, Rathouz PJ, Sidney S, Liu K, Lauderdale DS (December 2008). "Short sleep duration and incident coronary artery calcification". JAMA. 300 (24): 2859–66. doi:10.1001/jama.2008.867. PMC 2661105. PMID 19109114.
  47. ^ Provost EB, Madhloum N, Int Panis L, De Boever P, Nawrot TS (2015). "Carotid intima-media thickness, a marker of subclinical atherosclerosis, and particulate air pollution exposure: the meta-analytical evidence". PLOS ONE. 10 (5): e0127014. Bibcode:2015PLoSO..1027014P. doi:10.1371/journal.pone.0127014. PMC 4430520. PMID 25970426.
  48. ^ Adar SD, Sheppard L, Vedal S, Polak JF, Sampson PD, Diez Roux AV, Budoff M, Jacobs DR, Barr RG, Watson K, Kaufman JD (April 23, 2013). "Fine particulate air pollution and the progression of carotid intima-medial thickness: a prospective cohort study from the multi-ethnic study of atherosclerosis and air pollution". PLOS Medicine. 10 (4): e1001430. doi:10.1371/journal.pmed.1001430. PMC 3637008. PMID 23637576. This early analysis from MESA suggests that higher long-term PM2.5 concentrations are associated with increased IMT progression and that greater reductions in PM2.5 are related to slower IMT progression.
  49. ^ Wang CH, Jeng JS, Yip PK, Chen CL, Hsu LI, Hsueh YM, et al. (April 2002). "Biological gradient between long-term arsenic exposure and carotid atherosclerosis". Circulation. 105 (15): 1804–1809. doi:10.1161/01.cir.0000015862.64816.b2. PMID 11956123. S2CID 535580.
  50. ^ "Treating Hypothyroidism Reduces Atherosclerosis Risk". American Family Physician. 69 (3): 656. 1 February 2004.
  51. ^ Bale BF, Doneen AL, Vigerust DJ (April 2017). "High-risk periodontal pathogens contribute to the pathogenesis of atherosclerosis". Postgraduate Medical Journal. 93 (1098): 215–220. doi:10.1136/postgradmedj-2016-134279. PMC 5520251. PMID 27899684.
  52. ^ . Archived from the original on 26 December 2007. Retrieved 2007-11-25.
  53. ^ Staprãns I, Rapp JH, Pan XM, Hardman DA, Feingold KR (April 1996). "Oxidized lipids in the diet accelerate the development of fatty streaks in cholesterol-fed rabbits". Arteriosclerosis, Thrombosis, and Vascular Biology. 16 (4): 533–8. doi:10.1161/01.atv.16.4.533. PMID 8624775.
  54. ^ Song JH, Fujimoto K, Miyazawa T (December 2000). "Polyunsaturated (n-3) fatty acids susceptible to peroxidation are increased in plasma and tissue lipids of rats fed docosahexaenoic acid-containing oils". The Journal of Nutrition. 130 (12): 3028–33. doi:10.1093/jn/130.12.3028. PMID 11110863.
  55. ^ Yap SC, Choo YM, Hew NF, Yap SF, Khor HT, Ong AS, Goh SH (December 1995). "Oxidative susceptibility of low density lipoprotein from rabbits fed atherogenic diets containing coconut, palm, or soybean oils". Lipids. 30 (12): 1145–50. doi:10.1007/BF02536616. PMID 8614305. S2CID 3960289.
  56. ^ Greco AV, Mingrone G (1990). "Serum and biliary lipid pattern in rabbits feeding a diet enriched with unsaturated fatty acids". Experimental Pathology. 40 (1): 19–33. doi:10.1016/S0232-1513(11)80281-1. PMID 2279534.
  57. ^ "Scientist, 98, challenges orthodoxy on causes of heart disease". medicalxpress.com.
  58. ^ Mattes RD (December 2005). "Fat taste and lipid metabolism in humans". Physiology & Behavior. 86 (5): 691–7. doi:10.1016/j.physbeh.2005.08.058. PMID 16249011. S2CID 33916150. The rancid odor of an oxidized fat is readily detectable
  59. ^ Dobarganes C, Márquez-Ruiz G (March 2003). "Oxidized fats in foods". Current Opinion in Clinical Nutrition and Metabolic Care. 6 (2): 157–163. doi:10.1097/00075197-200303000-00004. PMID 12589185. S2CID 21085461.
  60. ^ "Dietary Supplements". Food and Drug Administration. 4 February 2020.
  61. ^ Khan-Merchant N, Penumetcha M, Meilhac O, Parthasarathy S (November 2002). "Oxidized fatty acids promote atherosclerosis only in the presence of dietary cholesterol in low-density lipoprotein receptor knockout mice". The Journal of Nutrition. 132 (11): 3256–3262. doi:10.1093/jn/132.11.3256. PMID 12421837.
  62. ^ "Atherosclerosis". The Lecturio Medical Concept Library. Retrieved 2 July 2021.
  63. ^ Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Cayatte AJ, Mowery J (December 1992). "Atherosclerosis. Potential targets for stabilization and regression". Circulation. 86 (6 Suppl): III117–23. PMID 1424045.
  64. ^ a b Linton MF, Yancey PG, Davies SS, Jerome WG, Linton EF, Song WL, et al. (2000). "The Role of Lipids and Lipoproteins in Atherosclerosis". Endotext. PMID 26844337. NBK343489.
  65. ^ Robbins CS, Hilgendorf I, Weber GF, Theurl I, Iwamoto Y, Figueiredo JL, Gorbatov R, Sukhova GK, Gerhardt LM, Smyth D, Zavitz CC, Shikatani EA, Parsons M, van Rooijen N, Lin HY, Husain M, Libby P, Nahrendorf M, Weissleder R, Swirski FK (September 2013). "Local proliferation dominates lesional macrophage accumulation in atherosclerosis". Nature Medicine. 19 (9): 1166–72. doi:10.1038/nm.3258. PMC 3769444. PMID 23933982.
  66. ^ Miller JD (June 2013). "Cardiovascular calcification: Orbicular origins". Nature Materials. 12 (6): 476–478. Bibcode:2013NatMa..12..476M. doi:10.1038/nmat3663. PMID 23695741.
  67. ^ Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ (May 1987). "Compensatory enlargement of human atherosclerotic coronary arteries". The New England Journal of Medicine. 316 (22): 1371–5. doi:10.1056/NEJM198705283162204. PMID 3574413.
  68. ^ "Coronary atherosclerosis — the fibrous plaque with calcification". www.pathologyatlas.ro. Retrieved 2010-03-25.
  69. ^ Janoudi A, Shamoun FE, Kalavakunta JK, Abela GS (July 2016). "Cholesterol crystal-induced arterial inflammation and destabilization of atherosclerotic plaque". European Heart Journal. 37 (25): 1959–67. doi:10.1093/eurheartj/ehv653. PMID 26705388.
  70. ^ Maton A, Hopkins RL, McLaughlin CW, Johnson S, Warner MQ, LaHart D, et al. (1993). Human Biology and Health. Englewood Cliffs, NJ: Prentice Hall. ISBN 978-0-13-981176-0. OCLC 32308337.
  71. ^ a b . www.nhlbi.nih.gov. September 29, 2014. Archived from the original on 24 February 2015. Retrieved 2 July 2021.
  72. ^ Wang J, Michelitsch T, Wunderlin A, Mahadeva R (6 April 2009). "Aging as a consequence of misrepair -- A novel theory of aging". Nature Precedings. arXiv:0904.0575. doi:10.1038/npre.2009.2988.2. S2CID 2179468.
  73. ^ Wang-Michelitsch J, Michelitsch T (2015). "Aging as a process of accumulation of Misrepairs". arXiv:1503.07163 [q-bio.TO].
  74. ^ Wang-Michelitsch J, Michelitsch TM (2015). "Misrepair mechanism in the development of atherosclerotic plaques". arXiv:1505.01289 [q-bio.TO].
  75. ^ Ross R (January 1999). "Atherosclerosis--an inflammatory disease". The New England Journal of Medicine. 340 (2): 115–26. doi:10.1056/NEJM199901143400207. PMID 9887164.
  76. ^ Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R (July 2010). "Concept of vulnerable/unstable plaque". Arteriosclerosis, Thrombosis, and Vascular Biology. 30 (7): 1282–92. doi:10.1161/ATVBAHA.108.179739. PMID 20554950.
  77. ^ Didangelos A, Simper D, Monaco C, Mayr M (May 2009). "Proteomics of acute coronary syndromes". Current Atherosclerosis Reports. 11 (3): 188–95. doi:10.1007/s11883-009-0030-x. PMID 19361350. S2CID 41219190.
  78. ^ a b Tarkin JM, Dweck MR, Evans NR, Takx RA, Brown AJ, Tawakol A, et al. (February 2016). "Imaging Atherosclerosis". Circulation Research. 118 (4): 750–769. doi:10.1161/CIRCRESAHA.115.306247. PMC 4756468. PMID 26892971.
  79. ^ Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, et al. (September 1995). "A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association". Circulation. 92 (5): 1355–1374. doi:10.1161/01.CIR.92.5.1355. PMID 7648691.
  80. ^ Maseri A, Fuster V (April 2003). "Is there a vulnerable plaque?". Circulation. 107 (16): 2068–71. doi:10.1161/01.CIR.0000070585.48035.D1. PMID 12719286.
  81. ^ McGill HC, McMahan CA, Gidding SS (March 2008). "Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study". Circulation. 117 (9): 1216–27. doi:10.1161/CIRCULATIONAHA.107.717033. PMID 18316498.
  82. ^ McNeal CJ, Dajani T, Wilson D, Cassidy-Bushrow AE, Dickerson JB, Ory M (January 2010). "Hypercholesterolemia in youth: opportunities and obstacles to prevent premature atherosclerotic cardiovascular disease". Current Atherosclerosis Reports. 12 (1): 20–8. doi:10.1007/s11883-009-0072-0. PMID 20425267. S2CID 37833889.
  83. ^ Rice BH (2014). "Dairy and Cardiovascular Disease: A Review of Recent Observational Research". Current Nutrition Reports. 3 (2): 130–138. doi:10.1007/s13668-014-0076-4. PMC 4006120. PMID 24818071.
  84. ^ Kratz M, Baars T, Guyenet S (February 2013). "The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease". European Journal of Nutrition. 52 (1): 1–24. doi:10.1007/s00394-012-0418-1. PMID 22810464. S2CID 1360916.
  85. ^ Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, Hu FB (July 2014). "Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies". BMJ. 349: g4490. doi:10.1136/bmj.g4490. PMC 4115152. PMID 25073782.
  86. ^ Walker C, Reamy BV (April 2009). "Diets for cardiovascular disease prevention: what is the evidence?". American Family Physician. 79 (7): 571–8. PMID 19378874.
  87. ^ Nordmann AJ, Suter-Zimmermann K, Bucher HC, Shai I, Tuttle KR, Estruch R, Briel M (September 2011). "Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors". The American Journal of Medicine. 124 (9): 841–51.e2. doi:10.1016/j.amjmed.2011.04.024. PMID 21854893.
  88. ^ Paul P, Williams B, eds. (2009). "Cardiovascular, Circulatory, and Hematologic Function". Brunner & Suddarth's Textbook of Canadian Medical-surgical Nursing. Lippincott Williams & Wilkins. pp. 730–1047. ISBN 978-0-7817-9989-8.
  89. ^ a b Fonarow G (2003). "Aggressive treatment of atherosclerosis: The time is now". Cleve. Clin. J. Med. 70 (5): 431–434. doi:10.3949/ccjm.70.5.431. PMID 12785316.
  90. ^ Ambrose JA, Barua RS (May 2004). "The pathophysiology of cigarette smoking and cardiovascular disease: an update". Journal of the American College of Cardiology. 43 (10): 1731–7. doi:10.1016/j.jacc.2003.12.047. PMID 15145091.
  91. ^ Pigozzi F, Rizzo M, Fagnani F, Parisi A, Spataro A, Casasco M, Borrione P (June 2011). "Endothelial (dys)function: the target of physical exercise for prevention and treatment of cardiovascular disease". The Journal of Sports Medicine and Physical Fitness. 51 (2): 260–267. PMID 21681161.
  92. ^ Gupta, Keshav Kumar; Ali, Shair; Sanghera, Ranjodh Singh (June 2019). "Pharmacological Options in Atherosclerosis: A Review of the Existing Evidence". Cardiology and Therapy. 8 (1): 5–20. doi:10.1007/s40119-018-0123-0. ISSN 2193-8261. PMC 6525235. PMID 30543029.
  93. ^ Koh KK, Han SH, Oh PC, Shin EK, Quon MJ (April 2010). "Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction". Atherosclerosis. 209 (2): 307–13. doi:10.1016/j.atherosclerosis.2009.09.007. PMC 2962413. PMID 19800624.
  94. ^ Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, et al. (January 2013). "Statins for the primary prevention of cardiovascular disease". The Cochrane Database of Systematic Reviews. 1 (1): CD004816. doi:10.1002/14651858.CD004816.pub5. PMC 6481400. PMID 23440795.
  95. ^ Virani SS, Smith SC, Stone NJ, Grundy SM (April 2020). "Secondary Prevention for Atherosclerotic Cardiovascular Disease: Comparing Recent US and European Guidelines on Dyslipidemia". Circulation. 141 (14): 1121–1123. doi:10.1161/CIRCULATIONAHA.119.044282. PMID 32250694.
  96. ^ Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. (June 2019). "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Journal of the American College of Cardiology. 73 (24): e285–e350. doi:10.1016/j.jacc.2018.11.003. hdl:20.500.12749/1738. PMID 30423393.
  97. ^ Nanna MG, Wang TY, Xiang Q, Goldberg AC, Robinson JG, Roger VL, et al. (August 2019). "Sex Differences in the Use of Statins in Community Practice". Circulation: Cardiovascular Quality and Outcomes. 12 (8): e005562. doi:10.1161/CIRCOUTCOMES.118.005562. PMC 6903404. PMID 31416347.
  98. ^ Lee MT, Mahtta D, Ramsey DJ, Liu J, Misra A, Nasir K, et al. (July 2021). "Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease". JAMA Cardiology. 6 (7): 782–790. doi:10.1001/jamacardio.2021.0683. PMC 8060887. PMID 33881448.
  99. ^ Vos E, Rose CP (November 2005). "Questioning the benefits of statins". CMAJ. 173 (10): 1207, author reply 1210. doi:10.1503/cmaj.1050120. PMC 1277053. PMID 16275976.
  100. ^ Zhao DF, Edelman JJ, Seco M, Bannon PG, Wilson MK, Byrom MJ, Thourani V, Lamy A, Taggart DP, Puskas JD, Vallely MP (February 2017). "Coronary Artery Bypass Grafting With and Without Manipulation of the Ascending Aorta: A Network Meta-Analysis". Journal of the American College of Cardiology. 69 (8): 924–936. doi:10.1016/j.jacc.2016.11.071. PMID 28231944.
  101. ^ Vlasschaert C, Goss CJ, Pilkey NG, McKeown S, Holden RM (September 2020). "Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evidence? A Systematic Review of Controlled Trials". Nutrients. 12 (10): 2909. doi:10.3390/nu12102909. PMC 7598164. PMID 32977548.
  102. ^ Price PA, Faus SA, Williamson MK (February 2000). "Warfarin-induced artery calcification is accelerated by growth and vitamin D". Arteriosclerosis, Thrombosis, and Vascular Biology. 20 (2): 317–327. doi:10.1161/01.ATV.20.2.317. PMID 10669626.
  103. ^ Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, et al. (November 2004). "Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study". The Journal of Nutrition. 134 (11): 3100–3105. doi:10.1093/jn/134.11.3100. hdl:1765/10366. PMID 15514282.
  104. ^ "Vitamin K". Linus Pauling Institute at Oregon State University. from the original on 7 April 2010. Retrieved 2010-03-25.
  105. ^ Kong BS, Cho YH, Lee EJ (2014). "G protein-coupled estrogen receptor-1 is involved in the protective effect of protocatechuic aldehyde against endothelial dysfunction". PLOS ONE. 9 (11): e113242. Bibcode:2014PLoSO...9k3242K. doi:10.1371/journal.pone.0113242. PMC 4239058. PMID 25411835.
  106. ^ Kong BS, Im SJ, Lee YJ, Cho YH, Do YR, Byun JW, et al. (2016). "Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation". PLOS ONE. 11 (3): e0149394. Bibcode:2016PLoSO..1149394K. doi:10.1371/journal.pone.0149394. PMC 4803227. PMID 27002821.
  107. ^ "The top 10 causes of death". www.who.int. Retrieved 2020-01-26.
  108. ^ Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; & Mitchell, Richard N. (2007). Robbins Basic Pathology (8th ed.). Saunders Elsevier. pp. 348-351 ISBN 978-1-4160-2973-1
  109. ^ Strong, J. P.; McGill, H. C. (1969-05-06). "The pediatric aspects of atherosclerosis". Journal of Atherosclerosis Research. 9 (3): 251–265. doi:10.1016/S0368-1319(69)80020-7. ISSN 0368-1319. PMID 5346899.
  110. ^ Zieske, Arthur W.; Malcom, Gray T.; Strong, Jack P. (January 2002). "Natural history and risk factors of atherosclerosis in children and youth: The PDAY study". Pediatric Pathology & Molecular Medicine. 21 (2): 213–237. doi:10.1080/pdp.21.2.213.237. ISSN 1522-7952. PMID 11942537. S2CID 218896145.
  111. ^ Enos, William F. (1953-07-18). "Coronary Disease Among United States Soldiers Killed in Action in Korea". Journal of the American Medical Association. 152 (12): 1090–1093. doi:10.1001/jama.1953.03690120006002. ISSN 0002-9955. PMID 13052433.
  112. ^ "Stopping Heart Disease in Childhood". NutritionFacts.org. 15 July 2014. Retrieved 2022-12-08.
  113. ^ Wilson, Don P. (2000), Feingold, Kenneth R.; Anawalt, Bradley; Boyce, Alison; Chrousos, George (eds.), "Is Atherosclerosis a Pediatric Disease?", Endotext, South Dartmouth (MA): MDText.com, Inc., PMID 27809437, retrieved 2022-12-08
  114. ^ Strong, Jack P.; Malcom, Gray T.; Newman, William P.; Oalmann, Margaret C. (June 1992). "Early Lesions of Atherosclerosis in Childhood and Youth: Natural History and Risk Factors". Journal of the American College of Nutrition. 11 (sup1): 51S–54S. doi:10.1080/07315724.1992.10737984. ISSN 0731-5724. PMID 1619200.
  115. ^ Mendis, Shanthi; Nordet, P.; Fernandez-Britto, J.E.; Sternby, N. (2005-03-01). "Atherosclerosis in children and young adults: An overview of the World Health Organization and International Society and Federation of Cardiology study on Pathobiological Determinants of Atherosclerosis in Youth study (1985–1995)". Global Heart. 1 (1): 3. doi:10.1016/j.precon.2005.02.010. ISSN 2211-8179.
  116. ^ "Atherogenic". Merriam-Webster Dictionary.
  117. ^ Pfuntner A, Wier LM, Steiner C (December 2013). "Costs for Hospital Stays in the United States, 2011". HCUP Statistical Brief #168. Rockville, MD: Agency for Healthcare Research and Quality. PMID 24455786.
  118. ^ Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B (November 2007). "Effects of torcetrapib in patients at high risk for coronary events". The New England Journal of Medicine. 357 (21): 2109–22. doi:10.1056/NEJMoa0706628. PMID 17984165.
  119. ^ Nilsson J, Hansson GK, Shah PK (January 2005). "Immunomodulation of atherosclerosis: implications for vaccine development". Arteriosclerosis, Thrombosis, and Vascular Biology. 25 (1): 18–28. doi:10.1161/01.ATV.0000149142.42590.a2. PMID 15514204.
  120. ^ Spiteller G (November 2005). "The relation of lipid peroxidation processes with atherogenesis: a new theory on atherogenesis". Molecular Nutrition & Food Research. 49 (11): 999–1013. doi:10.1002/mnfr.200500055. PMID 16270286.
  121. ^ Berbée JF, Mol IM, Milne GL, Pollock E, Hoeke G, Lütjohann D, Monaco C, Rensen PC, van der Ploeg LH, Shchepinov MS (September 2017). "Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia". Atherosclerosis. 264: 100–107. doi:10.1016/j.atherosclerosis.2017.06.916. PMID 28655430. S2CID 21408028.
  122. ^ Tsikas D (September 2017). "Combating atherosclerosis with heavy PUFAs: Deuteron not proton is the first". Atherosclerosis. 264: 79–82. doi:10.1016/j.atherosclerosis.2017.07.018. PMID 28756876.
  123. ^ a b Chen WJ, Yin K, Zhao GJ, Fu YC, Tang CK (June 2012). "The magic and mystery of microRNA-27 in atherosclerosis". Atherosclerosis. 222 (2): 314–23. doi:10.1016/j.atherosclerosis.2012.01.020. PMID 22307089.
  124. ^ Sacco J, Adeli K (June 2012). "MicroRNAs: emerging roles in lipid and lipoprotein metabolism". Current Opinion in Lipidology. 23 (3): 220–5. doi:10.1097/MOL.0b013e3283534c9f. PMID 22488426. S2CID 23814795.
  125. ^ Bommer GT, MacDougald OA (March 2011). "Regulation of lipid homeostasis by the bifunctional SREBF2-miR33a locus". Cell Metabolism. 13 (3): 241–7. doi:10.1016/j.cmet.2011.02.004. PMC 3062104. PMID 21356514.
  126. ^ Rayner KJ, Sheedy FJ, Esau CC, Hussain FN, Temel RE, Parathath S, van Gils JM, Rayner AJ, Chang AN, Suarez Y, Fernandez-Hernando C, Fisher EA, Moore KJ (July 2011). "Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis". The Journal of Clinical Investigation. 121 (7): 2921–31. doi:10.1172/JCI57275. PMC 3223840. PMID 21646721.
  127. ^ Iwakiri Y (March 2012). "A role of miR-33 for cell cycle progression and cell proliferation". Cell Cycle. 11 (6): 1057–8. doi:10.4161/cc.11.6.19744. PMID 22395363.
  128. ^ Singaraja RR, Stahmer B, Brundert M, Merkel M, Heeren J, Bissada N, Kang M, Timmins JM, Ramakrishnan R, Parks JS, Hayden MR, Rinninger F (August 2006). "Hepatic ATP-binding cassette transporter A1 is a key molecule in high-density lipoprotein cholesteryl ester metabolism in mice". Arteriosclerosis, Thrombosis, and Vascular Biology. 26 (8): 1821–7. doi:10.1161/01.ATV.0000229219.13757.a2. PMID 16728652.
  129. ^ Zimmer S, Grebe A, Bakke SS, Bode N, Halvorsen B, Ulas T, Skjelland M, De Nardo D, Labzin LI, Kerksiek A, Hempel C, Heneka MT, Hawxhurst V, Fitzgerald ML, Trebicka J, Björkhem I, Gustafsson JÅ, Westerterp M, Tall AR, Wright SD, Espevik T, Schultze JL, Nickenig G, Lütjohann D, Latz E (April 2016). "Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming". Science Translational Medicine. 8 (333): 333ra50. doi:10.1126/scitranslmed.aad6100. PMC 4878149. PMID 27053774.
    • Lay summary in: Hesman Saey T (April 8, 2016). "A sugar can melt away cholesterol". Science News.org.
  130. ^ Wu H, Roks AJ (February 2014). "Genomic instability and vascular aging: a focus on nucleotide excision repair". Trends in Cardiovascular Medicine. 24 (2): 61–8. doi:10.1016/j.tcm.2013.06.005. PMID 23953979.
  131. ^ a b Bautista-Niño PK, Portilla-Fernandez E, Vaughan DE, Danser AH, Roks AJ (May 2016). "DNA Damage: A Main Determinant of Vascular Aging". International Journal of Molecular Sciences. 17 (5): 748. doi:10.3390/ijms17050748. PMC 4881569. PMID 27213333.
  132. ^ Shah AV, Bennett MR (December 2017). "DNA damage-dependent mechanisms of ageing and disease in the macro- and microvasculature". European Journal of Pharmacology. 816: 116–128. doi:10.1016/j.ejphar.2017.03.050. PMID 28347738. S2CID 1034518.
  133. ^ a b Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM (August 2002). "Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques". Circulation. 106 (8): 927–32. doi:10.1161/01.cir.0000026393.47805.21. PMID 12186795.
  134. ^ Ishida T, Ishida M, Tashiro S, Yoshizumi M, Kihara Y (2014). "Role of DNA damage in cardiovascular disease". Circulation Journal. 78 (1): 42–50. doi:10.1253/circj.CJ-13-1194. PMID 24334614.
  135. ^ a b Barrington WT, Lusis AJ (December 2017). "Atherosclerosis: Association between the gut microbiome and atherosclerosis". Nature Reviews. Cardiology. 14 (12): 699–700. doi:10.1038/nrcardio.2017.169. PMC 5815826. PMID 29099096.
  136. ^ Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S, et al. (October 2017). "The gut microbiome in atherosclerotic cardiovascular disease". Nature Communications. 8 (1): 845. Bibcode:2017NatCo...8..845J. doi:10.1038/s41467-017-00900-1. PMC 5635030. PMID 29018189.
  137. ^ a b c Harman JL, Jørgensen HF (October 2019). "The role of smooth muscle cells in plaque stability: Therapeutic targeting potential". British Journal of Pharmacology. 176 (19): 3741–3753. doi:10.1111/bph.14779. PMC 6780045. PMID 31254285.
  138. ^ Bennett MR, Sinha S, Owens GK (February 2016). "Vascular Smooth Muscle Cells in Atherosclerosis". Circulation Research. 118 (4): 692–702. doi:10.1161/CIRCRESAHA.115.306361. PMC 4762053. PMID 26892967.
  139. ^ Gomez D, Shankman LS, Nguyen AT, Owens GK (February 2013). "Detection of histone modifications at specific gene loci in single cells in histological sections". Nature Methods. 10 (2): 171–177. doi:10.1038/nmeth.2332. PMC 3560316. PMID 23314172.
  140. ^ a b Wang Y, Dubland JA, Allahverdian S, Asonye E, Sahin B, Jaw JE, et al. (May 2019). "Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis". Arteriosclerosis, Thrombosis, and Vascular Biology. 39 (5): 876–887. doi:10.1161/ATVBAHA.119.312434. PMC 6482082. PMID 30786740.
  141. ^ a b Chappell J, Harman JL, Narasimhan VM, Yu H, Foote K, Simons BD, et al. (December 2016). "Extensive Proliferation of a Subset of Differentiated, yet Plastic, Medial Vascular Smooth Muscle Cells Contributes to Neointimal Formation in Mouse Injury and Atherosclerosis Models". Circulation Research. 119 (12): 1313–1323. doi:10.1161/CIRCRESAHA.116.309799. PMC 5149073. PMID 27682618.
  142. ^ Durham AL, Speer MY, Scatena M, Giachelli CM, Shanahan CM (March 2018). "Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness". Cardiovascular Research. 114 (4): 590–600. doi:10.1093/cvr/cvy010. PMC 5852633. PMID 29514202.
  143. ^ Basatemur GL, Jørgensen HF, Clarke MC, Bennett MR, Mallat Z (December 2019). "Vascular smooth muscle cells in atherosclerosis". Nature Reviews. Cardiology. 16 (12): 727–744. doi:10.1038/s41569-019-0227-9. PMID 31243391. S2CID 195657448.

External links edit

 
Wikimedia Commons has media related to Atherosclerosis.
  •   Quotations related to Atherosclerosis at Wikiquote
  • Atherosclerosis at Curlie
  • Atherosclerosis pathophysiology-stages and types

February 15, 2024
atherosclerosis, confused, with, arteriosclerosis, journal, journal, pattern, disease, arteriosclerosis, characterized, development, abnormalities, called, lesions, walls, arteries, these, lesions, lead, narrowing, arterial, walls, buildup, atheromatous, plaqu. Not to be confused with Arteriosclerosis For the journal see Atherosclerosis journal Atherosclerosis is a pattern of the disease arteriosclerosis 8 characterized by development of abnormalities called lesions in walls of arteries These lesions may lead to narrowing of the arterial walls due to buildup of atheromatous plaques 9 10 At onset there are usually no symptoms but if they develop symptoms generally begin around middle age 1 In severe cases it can result in coronary artery disease stroke peripheral artery disease or kidney disorders depending on which body parts s the affected arteries are located in the body 1 AtherosclerosisOther namesArteriosclerotic vascular disease ASVD The progression of atherosclerosis narrowing exaggerated SpecialtyCardiology angiologySymptomsNone 1 ComplicationsCoronary artery disease stroke peripheral artery disease kidney problems 1 Usual onsetYouth worsens with age 2 CausesAccumulation of saturated fats smoking high blood pressure and diabetesRisk factorsHigh blood pressure diabetes smoking obesity family history unhealthy diet notably trans fat chronic Vitamin C deficiency 3 4 PreventionHealthy diet exercise not smoking maintaining a normal weight 5 MedicationStatins blood pressure medication aspirin 6 Frequency 100 gt 65 years old 7 The exact cause of atherosclerosis is unknown and is proposed to be multifactorial 1 Risk factors include abnormal cholesterol levels elevated levels of inflammatory biomarkers 11 high blood pressure diabetes smoking both active and passive smoking obesity genetic factors family history lifestyle habits and an unhealthy diet 4 Plaque is made up of fat cholesterol calcium and other substances found in the blood 9 The narrowing of arteries limits the flow of oxygen rich blood to parts of the body 9 Diagnosis is based upon a physical exam electrocardiogram and exercise stress test among others 12 Prevention guidelines include eating a healthy diet exercising not smoking and maintaining normal body weight 5 Treatment of established disease may include medications to lower cholesterol such as statins blood pressure medication and anticoagulant therapies to reduce the risk of blood clot formation 6 As the disease state progresses more invasive strategies are applied such as percutaneous coronary intervention coronary artery bypass graft or carotid endarterectomy 6 Genetic factors are also strongly implicated in the disease process it is not entirely based on lifestyle choices 13 Atherosclerosis generally starts when a person is young and worsens with age 2 Almost all people are affected to some degree by the age of 65 7 It is the number one cause of death and disability in developed countries 14 15 16 Though it was first described in 1575 17 there is evidence suggesting that this disease state is genetically inherent in the broader human population with its origins tracing back to genetic mutations that may have occurred more than two million years ago during the evolution of hominin ancestors of modern human beings 18 Contents 1 Signs and symptoms 2 Risk factors 2 1 Modifiable 2 2 Nonmodifiable 2 3 Lesser or uncertain 2 4 Dietary 3 Pathophysiology 3 1 Cellular 3 2 Calcification and lipids 3 3 Visible features 3 4 Rupture and stenosis 3 5 Accelerated growth of plaques 3 6 Components 4 Diagnosis 5 Prevention 5 1 Diet 5 2 Exercise 6 Treatment 6 1 Statins 6 2 Surgery 6 3 Other 7 Epidemiology 8 Etymology 9 Economics 10 Research 10 1 Lipids 10 2 miRNA 10 3 DNA damage 10 4 Microorganisms 10 5 Vascular smooth muscle cells 11 References 12 External linksSigns and symptoms editAtherosclerosis is asymptomatic for decades because the arteries enlarge at all plaque locations thus there is no effect on blood flow 19 Even most plaque ruptures do not produce symptoms until enough narrowing or closure of an artery due to clots occurs Signs and symptoms only occur after severe narrowing or closure impedes blood flow to different organs enough to induce symptoms 20 Most of the time patients realize that they have the disease only when they experience other cardiovascular disorders such as stroke or heart attack These symptoms however still vary depending on which artery or organ is affected 21 Early atherosclerotic processes likely begin in childhood Fibrous and gelatinous lesions have been observed in the coronary arteries of children 22 Fatty streaks have been observed in the coronary arteries of juveniles 22 While coronary artery disease is more prevalent in men than women atherosclerosis of the cerebral arteries and strokes equally affect both sexes 23 Marked narrowing in the coronary arteries which are responsible for bringing oxygenated blood to the heart can produce symptoms such as chest pain of angina and shortness of breath sweating nausea dizziness or lightheadedness breathlessness or palpitations 21 Abnormal heart rhythms called arrhythmias the heart beating either too slowly or too quickly are another consequence of ischemia 24 Carotid arteries supply blood to the brain and neck 24 Marked narrowing of the carotid arteries can present with symptoms such as a feeling of weakness being unable to think straight difficulty speaking dizziness difficulty in walking or standing up straight blurred vision numbness of the face arms and legs severe headache and loss of consciousness These symptoms are also related to stroke death of brain cells Stroke is caused by marked narrowing or closure of arteries going to the brain lack of adequate blood supply leads to the death of the cells of the affected tissue 25 Peripheral arteries which supply blood to the legs arms and pelvis also experience marked narrowing due to plaque rupture and clots Symptoms of the narrowing are numbness within the arms or legs as well as pain Another significant location for plaque formation is the renal arteries which supply blood to the kidneys Plaque occurrence and accumulation lead to decreased kidney blood flow and chronic kidney disease which like in all other areas is typically asymptomatic until late stages 21 In 2004 US data indicated that in 66 of men and 47 of women the first symptom of atherosclerotic cardiovascular disease was a heart attack or sudden cardiac death defined as death within one hour of onset of the symptom 26 Case studies have included autopsies of U S soldiers killed in World War II and the Korean War A much cited report involved the autopsies of 300 U S soldiers killed in Korea Although the average age of the men was 22 1 years 77 3 percent had gross evidence of coronary arteriosclerosis 27 Risk factors editSee also Lipoprotein and Lipoprotein a nbsp Atherosclerosis and lipoproteinsThe atherosclerotic process is not well understood Atherosclerosis is associated with inflammatory processes in the endothelial cells of the vessel wall associated with retained low density lipoprotein LDL particles 28 29 This retention may be a cause an effect or both of the underlying inflammatory process 30 The presence of the plaque induces the muscle cells of the blood vessel to stretch compensating for the additional bulk The endothelial lining then thickens increasing the separation between the plaque and lumen The thickening somewhat offsets the narrowing caused by the growth of the plaque but moreover it causes the wall to stiffen and become less compliant to stretching with each heartbeat 31 Modifiable edit Western pattern diet 32 Abdominal obesity 32 Insulin resistance 32 Diabetes 32 Dyslipidemia 32 Hypertension 32 Trans fat 32 Tobacco smoking 32 Bacterial infections 33 HIV AIDS 34 Nonmodifiable edit South Asian descent 35 36 Advanced age 32 37 Genetic abnormalities 32 Family history 32 Coronary anatomy and branch pattern 38 Lesser or uncertain edit Thrombophilia 39 40 41 Saturated fat 32 42 Excessive carbohydrates 32 43 Elevated triglycerides 32 Systemic inflammation 44 Hyperinsulinemia 45 Sleep deprivation 46 Air pollution 47 48 Sedentary lifestyle 32 Arsenic poisoning 49 Alcohol 32 failed verification Chronic stress 32 Hypothyroidism 50 Periodontal disease 51 Dietary edit The relation between dietary fat and atherosclerosis is controversial The USDA in its food pyramid promotes a diet of about 64 carbohydrates from total calories The American Heart Association the American Diabetes Association and the National Cholesterol Education Program make similar recommendations In contrast Prof Walter Willett Harvard School of Public Health PI of the second Nurses Health Study recommends much higher levels of fat especially of monounsaturated and polyunsaturated fat 52 These dietary recommendations reach a consensus though against consumption of trans fats citation needed The role of eating oxidized fats rancid fats in humans is not clear Rabbits fed rancid fats develop atherosclerosis faster 53 Rats fed DHA containing oils experienced marked disruptions to their antioxidant systems and accumulated significant amounts of phospholipid hydroperoxide in their blood livers and kidneys 54 Rabbits fed atherogenic diets containing various oils were found to undergo the most oxidative susceptibility of LDL via polyunsaturated oils 55 In another study rabbits fed heated soybean oil grossly induced atherosclerosis and marked liver damage were histologically and clinically demonstrated 56 However Fred Kummerow claims that it is not dietary cholesterol but oxysterols or oxidized cholesterols from fried foods and smoking that are the culprit 57 Rancid fats and oils taste very unpleasant in even small amounts so people avoid eating them 58 It is very difficult to measure or estimate the actual human consumption of these substances 59 Highly unsaturated omega 3 rich oils such as fish oil when being sold in pill form can hide the taste of oxidized or rancid fat that might be present In the US the health food industry s dietary supplements are self regulated and outside of FDA regulations 60 To properly protect unsaturated fats from oxidation it is best to keep them cool and in oxygen free environments 61 Pathophysiology editAtherogenesis is the developmental process of atheromatous plaques It is characterized by a remodeling of arteries leading to subendothelial accumulation of fatty substances called plaques The buildup of an atheromatous plaque is a slow process developed over a period of several years through a complex series of cellular events occurring within the arterial wall and in response to a variety of local vascular circulating factors One recent hypothesis suggests that for unknown reasons leukocytes such as monocytes or basophils begin to attack the endothelium of the artery lumen in cardiac muscle The ensuing inflammation leads to the formation of atheromatous plaques in the arterial tunica intima a region of the vessel wall located between the endothelium and the tunica media The bulk of these lesions is made of excess fat collagen and elastin At first as the plaques grow only wall thickening occurs without any narrowing Stenosis is a late event which may never occur and is often the result of repeated plaque rupture and healing responses not just the atherosclerotic process by itself 62 Cellular edit nbsp Micrograph of an artery that supplies the heart showing significant atherosclerosis and marked luminal narrowing Tissue has been stained using Masson s trichrome Early atherogenesis is characterized by the adherence of blood circulating monocytes a type of white blood cell to the vascular bed lining the endothelium then by their migration to the sub endothelial space and further activation into monocyte derived macrophages 63 The primary documented driver of this process is oxidized lipoprotein particles within the wall beneath the endothelial cells though upper normal or elevated concentrations of blood glucose also plays a major role and not all factors are fully understood Fatty streaks may appear and disappear citation needed Low density lipoprotein LDL particles in blood plasma invade the endothelium and become oxidized creating risk of cardiovascular disease A complex set of biochemical reactions regulates the oxidation of LDL involving enzymes such as Lp LpA2 and free radicals in the endothelium 64 Initial damage to the endothelium results in an inflammatory response Monocytes enter the artery wall from the bloodstream with platelets adhering to the area of insult This may be promoted by redox signaling induction of factors such as VCAM 1 which recruit circulating monocytes and M CSF which is selectively required for the differentiation of monocytes to macrophages The monocytes differentiate into macrophages which proliferate locally 65 ingest oxidized LDL slowly turning into large foam cells so called because of their changed appearance resulting from the numerous internal cytoplasmic vesicles and resulting high lipid content Under the microscope the lesion now appears as a fatty streak Foam cells eventually die and further propagate the inflammatory process citation needed In addition to these cellular activities there is also smooth muscle proliferation and migration from the tunica media into the intima in response to cytokines secreted by damaged endothelial cells This causes the formation of a fibrous capsule covering the fatty streak Intact endothelium can prevent this smooth muscle proliferation by releasing nitric oxide citation needed Calcification and lipids edit Calcification forms among vascular smooth muscle cells of the surrounding muscular layer specifically in the muscle cells adjacent to atheromas and on the surface of atheroma plaques and tissue 66 In time as cells die this leads to extracellular calcium deposits between the muscular wall and outer portion of the atheromatous plaques With the atheromatous plaque interfering with the regulation of the calcium deposition it accumulates and crystallizes A similar form of intramural calcification presenting the picture of an early phase of arteriosclerosis appears to be induced by many drugs that have an antiproliferative mechanism of action Rainer Liedtke 2008 citation needed Cholesterol is delivered into the vessel wall by cholesterol containing low density lipoprotein LDL particles To attract and stimulate macrophages the cholesterol must be released from the LDL particles and oxidized a key step in the ongoing inflammatory process The process is worsened if it is insufficient high density lipoprotein HDL the lipoprotein particle that removes cholesterol from tissues and carries it back to the liver 64 The foam cells and platelets encourage the migration and proliferation of smooth muscle cells which in turn ingest lipids become replaced by collagen and transform into foam cells themselves A protective fibrous cap normally forms between the fatty deposits and the artery lining the intima citation needed These capped fatty deposits now called atheromas produce enzymes that cause the artery to enlarge over time As long as the artery enlarges sufficiently to compensate for the extra thickness of the atheroma then no narrowing stenosis of the opening lumen occurs The artery becomes expanded with an egg shaped cross section still with a circular opening If the enlargement is beyond proportion to the atheroma thickness then an aneurysm is created 67 Visible features edit nbsp Severe atherosclerosis of the aorta Autopsy specimen Although arteries are not typically studied microscopically two plaque types can be distinguished 68 The fibro lipid fibro fatty plaque is characterized by an accumulation of lipid laden cells underneath the intima of the arteries typically without narrowing the lumen due to compensatory expansion of the bounding muscular layer of the artery wall Beneath the endothelium there is a fibrous cap covering the atheromatous core of the plaque The core consists of lipid laden cells macrophages and smooth muscle cells with elevated tissue cholesterol and cholesterol ester content fibrin proteoglycans collagen elastin and cellular debris In advanced plaques the central core of the plaque usually contains extracellular cholesterol deposits released from dead cells which form areas of cholesterol crystals with empty needle like clefts At the periphery of the plaque are younger foamy cells and capillaries These plaques usually produce the most damage to the individual when they rupture Cholesterol crystals may also play a role 69 The fibrous plaque is also localized under the intima within the wall of the artery resulting in thickening and expansion of the wall and sometimes spotty localized narrowing of the lumen with some atrophy of the muscular layer The fibrous plaque contains collagen fibers eosinophilic precipitates of calcium hematoxylinophilic and rarely lipid laden cells citation needed In effect the muscular portion of the artery wall forms small aneurysms just large enough to hold the atheroma that are present The muscular portion of artery walls usually remains strong even after they have remodeled to compensate for the atheromatous plaques citation needed However atheromas within the vessel wall are soft and fragile with little elasticity Arteries constantly expand and contract with each heartbeat i e the pulse In addition the calcification deposits between the outer portion of the atheroma and the muscular wall as they progress lead to a loss of elasticity and stiffening of the artery as a whole citation needed The calcification deposits 70 after they have become sufficiently advanced are partially visible on coronary artery computed tomography or electron beam tomography EBT as rings of increased radiographic density forming halos around the outer edges of the atheromatous plaques within the artery wall On CT gt 130 units on the Hounsfield scale some argue for 90 units has been the radiographic density usually accepted as clearly representing tissue calcification within arteries These deposits demonstrate unequivocal evidence of the disease relatively advanced even though the lumen of the artery is often still normal by angiography citation needed Rupture and stenosis edit nbsp Progression of atherosclerosis to late complicationsAlthough the disease process tends to be slowly progressive over decades it usually remains asymptomatic until an atheroma ulcerates which leads to immediate blood clotting at the site of the atheroma ulcer This triggers a cascade of events that leads to clot enlargement which may quickly obstruct the flow of blood A complete blockage leads to ischemia of the myocardial heart muscle and damage This process is the myocardial infarction or heart attack 71 If the heart attack is not fatal fibrous organization of the clot within the lumen ensues covering the rupture but also producing stenosis or closure of the lumen or over time and after repeated ruptures resulting in a persistent usually localized stenosis or blockage of the artery lumen Stenoses can be slowly progressive whereas plaque ulceration is a sudden event that occurs specifically in atheromas with thinner weaker fibrous caps that have become unstable 71 Repeated plaque ruptures ones not resulting in total lumen closure combined with the clot patch over the rupture and healing response to stabilize the clot is the process that produces most stenoses over time The stenotic areas tend to become more stable despite increased flow velocities at these narrowings Most major blood flow stopping events occur at large plaques which before their rupture produced very little if any stenosis citation needed From clinical trials 20 is the average stenosis at plaques that subsequently rupture with resulting complete artery closure Most severe clinical events do not occur at plaques that produce high grade stenosis From clinical trials only 14 of heart attacks occur from artery closure at plaques producing a 75 or greater stenosis before the vessel closing citation needed If the fibrous cap separating a soft atheroma from the bloodstream within the artery ruptures tissue fragments are exposed and released These tissue fragments are very clot promoting containing collagen and tissue factor they activate platelets and activate the system of coagulation The result is the formation of a thrombus blood clot overlying the atheroma which obstructs blood flow acutely With the obstruction of blood flow downstream tissues are starved of oxygen and nutrients If this is the myocardium heart muscle angina cardiac chest pain or myocardial infarction heart attack develops citation needed Accelerated growth of plaques edit The distribution of atherosclerotic plaques in a part of arterial endothelium is inhomogeneous The multiple and focal development of atherosclerotic changes is similar to that in the development of amyloid plaques in the brain and that of age spots on the skin Misrepair accumulation aging theory suggests that misrepair mechanisms 72 73 play an important role in the focal development of atherosclerosis 74 Development of a plaque is a result of repair of injured endothelium Because of the infusion of lipids into sub endothelium the repair has to end up with altered remodeling of local endothelium This is the manifestation of a misrepair Important is this altered remodeling makes the local endothelium have increased fragility to damage and have reduced repair efficiency As a consequence this part of endothelium has an increased risk factor of being injured and improperly repaired Thus the accumulation of misrepairs of endothelium is focalized and self accelerating In this way the growing of a plaque is also self accelerating Within a part of the arterial wall the oldest plaque is always the biggest and is the most dangerous one to cause blockage of a local artery citation needed Components edit The plaque is divided into three distinct components The atheroma lump of gruel from Greek ἀ8hra athera gruel which is the nodular accumulation of a soft flaky yellowish material at the center of large plaques composed of macrophages nearest the lumen of the artery citation needed Underlying areas of cholesterol crystals citation needed Calcification at the outer base of older or more advanced lesions Atherosclerotic lesions or atherosclerotic plaques are separated into two broad categories Stable and unstable also called vulnerable 75 The pathobiology of atherosclerotic lesions is very complicated but generally stable atherosclerotic plaques which tend to be asymptomatic are rich in extracellular matrix and smooth muscle cells On the other hand unstable plaques are rich in macrophages and foam cells and the extracellular matrix separating the lesion from the arterial lumen also known as the fibrous cap is usually weak and prone to rupture 76 Ruptures of the fibrous cap expose thrombogenic material such as collagen 77 to the circulation and eventually induce thrombus formation in the lumen Upon formation intraluminal thrombi can occlude arteries outright e g coronary occlusion but more often they detach move into the circulation and eventually occlude smaller downstream branches causing thromboembolism citation needed Apart from thromboembolism chronically expanding atherosclerotic lesions can cause complete closure of the lumen Chronically expanding lesions are often asymptomatic until lumen stenosis is so severe usually over 80 that blood supply to downstream tissue s is insufficient resulting in ischemia These complications of advanced atherosclerosis are chronic slowly progressive and cumulative Most commonly soft plaque suddenly ruptures see vulnerable plaque causing the formation of a thrombus that will rapidly slow or stop blood flow leading to the death of the tissues fed by the artery in approximately five minutes This event is called an infarction citation needed Diagnosis edit nbsp CT image of atherosclerosis of the abdominal aorta Woman of 70 years old with hypertension and dyslipidemia nbsp Microphotography of arterial wall with calcified violet color atherosclerotic plaque hematoxylin and eosin stain Areas of severe narrowing stenosis detectable by angiography and to a lesser extent stress testing have long been the focus of human diagnostic techniques for cardiovascular disease in general However these methods focus on detecting only severe narrowing not the underlying atherosclerosis disease 78 As demonstrated by human clinical studies most severe events occur in locations with heavy plaque yet little or no lumen narrowing present before debilitating events suddenly occur Plaque rupture can lead to artery lumen occlusion within seconds to minutes and potential permanent debility and sometimes sudden death citation needed Plaques that have ruptured are called complicated lesions The extracellular matrix of the lesion breaks usually at the shoulder of the fibrous cap that separates the lesion from the arterial lumen where the exposed thrombogenic components of the plaque mainly collagen will trigger thrombus formation The thrombus then travels downstream to other blood vessels where the blood clot may partially or completely block blood flow If the blood flow is completely blocked cell deaths occur due to the lack of oxygen supply to nearby cells resulting in necrosis 79 The narrowing or obstruction of blood flow can occur in any artery within the body Obstruction of arteries supplying the heart muscle results in a heart attack while the obstruction of arteries supplying the brain results in an ischaemic stroke citation needed nbsp Doppler ultrasound of right internal carotid artery with calcified and non calcified plaques showing less than 70 stenosisLumen stenosis that is greater than 75 was considered the hallmark of clinically significant disease in the past because recurring episodes of angina and abnormalities in stress tests are only detectable at that particular severity of stenosis However clinical trials have shown that only about 14 of clinically debilitating events occur at sites with more than 75 stenosis The majority of cardiovascular events that involve sudden rupture of the atheroma plaque do not display any evident narrowing of the lumen Thus greater attention has been focused on vulnerable plaque from the late 1990s onwards 80 Besides the traditional diagnostic methods such as angiography and stress testing other detection techniques have been developed in the past decades for earlier detection of atherosclerotic disease Some of the detection approaches include anatomical detection and physiologic measurement citation needed Examples of anatomical detection methods include coronary calcium scoring by CT carotid IMT intimal media thickness measurement by ultrasound and intravascular ultrasound IVUS Examples of physiologic measurement methods include lipoprotein subclass analysis HbA1c hs CRP and homocysteine citation needed Both anatomic and physiologic methods allow early detection before symptoms show up disease staging and tracking of disease progression Anatomic methods are more expensive and some of them are invasive in nature such as IVUS On the other hand physiologic methods are often less expensive and safer But they do not quantify the current state of the disease or directly track progression In recent years developments in nuclear imaging techniques such as PET and SPECT have provided ways of estimating the severity of atherosclerotic plaques 78 Prevention editUp to 90 of cardiovascular disease may be preventable if established risk factors are avoided 81 82 Medical management of atherosclerosis first involves modification to risk factors for example via smoking cessation and diet restrictions Prevention then is generally by eating a healthy diet exercising not smoking and maintaining a normal weight 5 Diet edit Changes in diet may help prevent the development of atherosclerosis Tentative evidence suggests that a diet containing dairy products has no effect on or decreases the risk of cardiovascular disease 83 84 A diet high in fruits and vegetables decreases the risk of cardiovascular disease and death 85 Evidence suggests that the Mediterranean diet may improve cardiovascular results 86 There is also evidence that a Mediterranean diet may be better than a low fat diet in bringing about long term changes to cardiovascular risk factors e g lower cholesterol level and blood pressure 87 Exercise edit A controlled exercise program combats atherosclerosis by improving circulation and functionality of the vessels Exercise is also used to manage weight in patients who are obese lower blood pressure and decrease cholesterol Often lifestyle modification is combined with medication therapy For example statins help to lower cholesterol Antiplatelet medications like aspirin help to prevent clots and a variety of antihypertensive medications are routinely used to control blood pressure If the combined efforts of risk factor modification and medication therapy are not sufficient to control symptoms or fight imminent threats of ischemic events a physician may resort to interventional or surgical procedures to correct the obstruction 88 Treatment editTreatment of established disease may include medications to lower cholesterol such as statins blood pressure medication or medications that decrease clotting such as aspirin 6 A number of procedures may also be carried out such as percutaneous coronary intervention coronary artery bypass graft or carotid endarterectomy 6 Medical treatments often focus on alleviating symptoms However measures which focus on decreasing underlying atherosclerosis as opposed to simply treating symptoms are more effective 89 Non pharmaceutical means are usually the first method of treatment such as stopping smoking and practicing regular exercise 90 91 If these methods do not work medicines are usually the next step in treating cardiovascular diseases and with improvements have increasingly become the most effective method over the long term 92 The key to the more effective approaches is to combine multiple different treatment strategies 93 In addition for those approaches such as lipoprotein transport behaviors which have been shown to produce the most success adopting more aggressive combination treatment strategies taken on a daily basis and indefinitely has generally produced better results both before and especially after people are symptomatic 89 Statins edit The group of medications referred to as statins are widely prescribed for treating atherosclerosis They have shown benefit in reducing cardiovascular disease and mortality in those with high cholesterol with few side effects 94 Secondary prevention therapy which includes high intensity statins and aspirin is recommended by multi society guidelines for all patients with history of ASCVD atherosclerotic cardiovascular disease to prevent recurrence of coronary artery disease ischemic stroke or peripheral arterial disease 95 96 However prescription of and adherence to these guideline concordant therapies is lacking particularly among young patients and women 97 98 Statins work by inhibiting HMG CoA hydroxymethylglutaryl coenzyme A reductase a hepatic rate limiting enzyme in cholesterol s biochemical production pathway By inhibiting this rate limiting enzyme the body is unable to produce cholesterol endogenously therefore reducing serum LDL cholesterol This reduced endogenous cholesterol production triggers the body to then pull cholesterol from other cellular sources enhancing serum HDL cholesterol citation needed These data are primarily in middle age men and the conclusions are less clear for women and people over the age of 70 99 Surgery edit When atherosclerosis has become severe and caused irreversible ischemia such as tissue loss in the case of peripheral artery disease surgery may be indicated Vascular bypass surgery can re establish flow around the diseased segment of artery and angioplasty with or without stenting can reopen narrowed arteries and improve blood flow Coronary artery bypass grafting without manipulation of the ascending aorta has demonstrated reduced rates of postoperative stroke and mortality compared to traditional on pump coronary revascularization 100 Other edit There is evidence that some anticoagulants particularly warfarin which inhibit clot formation by interfering with Vitamin K metabolism may actually promote arterial calcification in the long term despite reducing clot formation in the short term 101 102 103 104 excessive citations Also small molecules such as 3 hydroxybenzaldehyde and protocatechuic aldehyde have shown vasculoprotective effects to reduce risk of atherosclerosis 105 106 Epidemiology editCardiovascular disease which is predominantly the clinical manifestation of atherosclerosis is one of the leading causes of death worldwide 107 Almost all children older than age 10 in developed countries have aortic fatty streaks with coronary fatty streaks beginning in adolescence 108 109 110 In 1953 a study was published which examined the results of 300 autopsies performed on U S soldiers who had died in the Korean War Despite the average age of the soldiers being just 22 years old 77 of them had visible signs of coronary atherosclerosis This study showed that heart disease could affect people at a younger age and was not just a problem for older individuals 111 112 113 In 1992 a report had shown that microscopic fatty streaks were seen in the left anterior descending artery in over 50 of children aged 10 14 and 8 had even more advanced lesions with more accumulations of extracellular lipid 114 In a 2005 report of a study done between 1985 and 1995 it was found that around 87 of aortas and 30 of coronary arteries in age group 5 14 years had fatty streaks which increased with age 115 Etymology editThe following terms are similar yet distinct in both spelling and meaning and can be easily confused arteriosclerosis arteriolosclerosis and atherosclerosis Arteriosclerosis is a general term describing any hardening and loss of elasticity of medium or large arteries from Greek ἀrthria arteria artery and sklhrwsis sklerosis hardening arteriolosclerosis is any hardening and loss of elasticity of arterioles small arteries atherosclerosis is a hardening of an artery specifically due to an atheromatous plaque from Ancient Greek ἀ8hra athḗra gruel The term atherogenic is used for substances or processes that cause formation of atheroma 116 Economics editIn 2011 coronary atherosclerosis was one of the top ten most expensive conditions seen during inpatient hospitalizations in the US with aggregate inpatient hospital costs of 10 4 billion 117 Research editLipids edit An indication of the role of high density lipoprotein HDL on atherosclerosis has been with the rare Apo A1 Milano human genetic variant of this HDL protein A small short term trial using bacterial synthesized human Apo A1 Milano HDL in people with unstable angina produced a fairly dramatic reduction in measured coronary plaque volume in only six weeks vs the usual increase in plaque volume in those randomized to placebo The trial was published in JAMA in early 2006 citation needed Ongoing work starting in the 1990s may lead to human clinical trials probably by about 2008 needs update These may use synthesized Apo A1 Milano HDL directly or they may use gene transfer methods to pass the ability to synthesize the Apo A1 Milano HDLipoprotein citation needed Methods to increase HDL particle concentrations which in some animal studies largely reverses and removes atheromas are being developed and researched citation needed However increasing HDL by any means is not necessarily helpful For example the drug torcetrapib is the most effective agent currently known for raising HDL by up to 60 However in clinical trials it also raised deaths by 60 All studies regarding this drug were halted in December 2006 118 The actions of macrophages drive atherosclerotic plaque progression Immunomodulation of atherosclerosis is the term for techniques that modulate immune system function to suppress this macrophage action 119 Involvement of lipid peroxidation chain reaction in atherogenesis 120 triggered research on the protective role of the heavy isotope deuterated polyunsaturated fatty acids D PUFAs that are less prone to oxidation than ordinary PUFAs H PUFAs PUFAs are essential nutrients they are involved in metabolism in that very form as they are consumed with food In transgenic mice that are a model for human like lipoprotein metabolism adding D PUFAs to diet indeed reduced body weight gain improved cholesterol handling and reduced atherosclerotic damage to the aorta 121 122 miRNA edit MicroRNAs miRNAs have complementary sequences in the 3 UTR and 5 UTR of target mRNAs of protein coding genes and cause mRNA cleavage or repression of translational machinery In diseased vascular vessels miRNAs are dysregulated and highly expressed miR 33 is found in cardiovascular diseases 123 It is involved in atherosclerotic initiation and progression including lipid metabolism insulin signaling and glucose homeostatis cell type progression and proliferation and myeloid cell differentiation It was found in rodents that the inhibition of miR 33 will raise HDL level and the expression of miR 33 is down regulated in humans with atherosclerotic plaques 124 125 126 miR 33a and miR 33b are located on intron 16 of human sterol regulatory element binding protein 2 SREBP2 gene on chromosome 22 and intron 17 of SREBP1 gene on chromosome 17 127 miR 33a b regulates cholesterol lipid homeostatis by binding in the 3 UTRs of genes involved in cholesterol transport such as ATP binding cassette ABC transporters and enhance or represses its expression Study have shown that ABCA1 mediates transport of cholesterol from peripheral tissues to Apolipoprotein 1 and it is also important in the reverse cholesterol transport pathway where cholesterol is delivered from peripheral tissue to the liver where it can be excreted into bile or converted to bile acids prior to excretion 123 Therefore we know that ABCA1 plays an important role in preventing cholesterol accumulation in macrophages By enhancing miR 33 function the level of ABCA1 is decreased leading to decrease cellular cholesterol efflux to apoA 1 On the other hand by inhibiting miR 33 function the level of ABCA1 is increased and increases the cholesterol efflux to apoA 1 Suppression of miR 33 will lead to less cellular cholesterol and higher plasma HDL level through the regulation of ABCA1 expression 128 The sugar cyclodextrin removed cholesterol that had built up in the arteries of mice fed a high fat diet 129 DNA damage edit Aging is the most important risk factor for cardiovascular problems The causative basis by which aging mediates its impact independently of other recognized risk factors remains to be determined Evidence has been reviewed for a key role of DNA damage in vascular aging 130 131 132 8 oxoG a common type of oxidative damage in DNA is found to accumulate in plaque vascular smooth muscle cells macrophages and endothelial cells 133 thus linking DNA damage to plaque formation DNA strand breaks also increased in atherosclerotic plaques 133 Werner syndrome WS is a premature aging condition in humans 134 WS is caused by a genetic defect in a RecQ helicase that is employed in several repair processes that remove damages from DNA WS patients develop a considerable burden of atherosclerotic plaques in their coronary arteries and aorta calcification of the aortic valve is also frequently observed 131 These findings link excessive unrepaired DNA damage to premature aging and early atherosclerotic plaque development see DNA damage theory of aging citation needed Microorganisms edit The microbiota all the microorganisms in the body can contribute to atherosclerosis in many ways modulation of the immune system changes in metabolism processing of nutrients and production of certain metabolites that can get into blood circulation 135 One such metabolite produced by gut bacteria is trimethylamine N oxide TMAO Its levels have been associated with atherosclerosis in human studies and animal research suggest that there can be a causal relation An association between the bacterial genes encoding trimethylamine lyases the enzymes involved in TMAO generation and atherosclerosis has been noted 136 135 Vascular smooth muscle cells edit Vascular smooth muscle cells play a key role in atherogenesis and were historically considered to be beneficial for plaque stability by forming a protective fibrous cap and synthesising strength giving extracellular matrix components 137 138 However in addition to the fibrous cap vascular smooth muscle cells also give rise to many of the cell types found within the plaque core and can modulate their phenotype to both promote and reduce plaque stability 137 139 140 141 Vascular smooth muscle cells exhibit pronounced plasticity within atherosclerotic plaque and can modify their gene expression profile to resemble various other cell types including macrophages myofibroblasts mesenchymal stem cells and osteochondrocytes 142 143 137 Importantly genetic lineage tracing experiments have unequivocally shown that 40 90 of plaque resident cells are vascular smooth muscle cell derived 140 141 therefore it is important to research the role of vascular smooth muscle cells in atherosclerosis to identify new therapeutic targets References edit a b c d e What Are the Signs and Symptoms of Atherosclerosis NHLBI NIH www nhlbi nih gov 22 June 2016 Retrieved 5 November 2017 a b What Causes Atherosclerosis NHLBI NIH www nhlbi nih gov 22 June 2016 Retrieved 6 November 2017 New Concept of Heart Disease Posits Vitamin C Deficiency as Culprit DAIC Diagnostic and Interventional Cardiology 27 April 2015 Retrieved 2022 02 06 a b Who Is at Risk for Atherosclerosis www nhlbi nih gov 22 June 2016 Retrieved 5 November 2017 a b c How Can Atherosclerosis Be Prevented or Delayed NHLBI NIH www nhlbi nih gov 22 June 2016 Retrieved 6 November 2017 a b c d e How Is Atherosclerosis Treated NHLBI NIH www nhlbi nih gov 22 June 2016 Retrieved 6 November 2017 a b Aronow WS Fleg JL Rich MW 2013 Tresch and Aronow s Cardiovascular Disease in the Elderly Fifth Edition CRC Press p 171 ISBN 978 1 84214 544 9 Arteriosclerosis atherosclerosis Symptoms and causes Mayo Clinic Retrieved 2021 05 06 a b c What Is Atherosclerosis NHLBI NIH www nhlbi nih gov 22 June 2016 Retrieved 6 November 2017 Tsukahara Tamotsu Tsukahara Ryoko Haniu Hisao Matsuda Yoshikazu Murakami Murofushi Kimiko 2015 09 05 Cyclic phosphatidic acid inhibits the secretion of vascular endothelial growth factor from diabetic human coronary artery endothelial cells through peroxisome proliferator activated receptor gamma Molecular and Cellular Endocrinology 412 320 329 doi 10 1016 j mce 2015 05 021 hdl 10069 35888 ISSN 0303 7207 PMID 26007326 S2CID 10454566 Lind L August 2003 Circulating markers of inflammation and atherosclerosis Atherosclerosis 169 2 203 214 doi 10 1016 s0021 9150 03 00012 1 PMID 12921971 How Is Atherosclerosis Diagnosed NHLBI NIH www nhlbi nih gov 22 June 2016 Retrieved 6 November 2017 Information US National Center for Biotechnology 1998 Atherosclerosis Genes and Disease Internet National Center for Biotechnology Information US retrieved 2023 11 21 Roth GA Mensah GA Johnson CO Addolorato G Ammirati E Baddour LM et al December 2020 Global Burden of Cardiovascular Diseases and Risk Factors 1990 2019 Update From the GBD 2019 Study Journal of the American College of Cardiology 76 25 2982 3021 doi 10 1016 j jacc 2020 11 010 PMC 7755038 PMID 33309175 Song P Fang Z Wang H Cai Y Rahimi K Zhu Y et al May 2020 Global and regional prevalence burden and risk factors for carotid atherosclerosis a systematic review meta analysis and modelling study The Lancet Global Health 8 5 e721 e729 doi 10 1016 S2214 109X 20 30117 0 hdl 10044 1 78967 PMID 32353319 S2CID 218474949 Topol EJ Califf RM 2007 Textbook of Cardiovascular Medicine Lippincott Williams amp Wilkins p 2 ISBN 978 0 7817 7012 5 Shor A 2008 Chlamydia Atherosclerosis Lesion Discovery Diagnosis and Treatment Springer Science amp Business Media p 8 ISBN 978 1 84628 810 4 Evolutionary gene loss may help explain why only humans are prone to heart attacks ScienceDaily Retrieved 2023 11 21 Ross R April 1993 The pathogenesis of atherosclerosis a perspective for the 1990s Nature 362 6423 801 9 Bibcode 1993Natur 362 801R doi 10 1038 362801a0 PMID 8479518 S2CID 4282916 Atherosclerosis Harvard Health Publications Harvard Health Publications Health Topics A Z 2011 a b c Atherosclerosis National Heart Lung and Blood Institute 2011 a b Velican D Velican C June 1979 Study of fibrous plaques occurring in the coronary arteries of children Atherosclerosis 33 2 201 205 doi 10 1016 0021 9150 79 90117 5 PMID 475879 Flora GC Baker AB Loewenson RB Klassen AC November 1968 A comparative study of cerebral atherosclerosis in males and females Circulation 38 5 859 69 doi 10 1161 01 CIR 38 5 859 PMID 5697685 a b Arrhythmia Heart and Stroke Foundation Heart disease Arrhythmia Heart and Stroke Foundation of Canada Archived from the original on 2014 02 03 Retrieved 2014 01 31 2011 Sims NR Muyderman H January 2010 Mitochondria oxidative metabolism and cell death in stroke PDF Biochimica et Biophysica Acta BBA Molecular Basis of Disease 1802 1 80 91 doi 10 1016 j bbadis 2009 09 003 PMID 19751827 Roquer J Ois Angel 2010 Preedy Victor R Watson Ronald R eds Atherosclerotic Burden and Mortality Handbook of Disease Burdens and Quality of Life Measures New York NY Springer pp 899 918 doi 10 1007 978 0 387 78665 0 51 ISBN 978 0 387 78665 0 retrieved 2023 11 10 Enos WF Holmes RH Beyer J 1953 Coronary disease among United States soldiers killed in action in Korea Preliminary Report JAMA 152 12 1090 93 doi 10 1001 jama 1953 03690120006002 PMID 13052433 The average age was calculated from the ages of 200 of the soldiers No age was recorded in nearly 100 of the men Li X Fang P Li Y Kuo YM Andrews AJ Nanayakkara G Johnson C Fu H Shan H Du F Hoffman NE Yu D Eguchi S Madesh M Koch WJ Sun J Jiang X Wang H Yang X June 2016 Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine Induced Endothelial Cell Activation Arteriosclerosis Thrombosis and Vascular Biology 36 6 1090 100 doi 10 1161 ATVBAHA 115 306964 PMC 4882253 PMID 27127201 Botts SR Fish JE Howe KL December 2021 Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis Emerging Insights Into Pathogenesis and Treatment Frontiers in Pharmacology 12 787541 doi 10 3389 fphar 2021 787541 PMC 8727904 PMID 35002720 Williams KJ Tabas I May 1995 The response to retention hypothesis of early atherogenesis Arteriosclerosis Thrombosis and Vascular Biology 15 5 551 61 doi 10 1161 01 ATV 15 5 551 PMC 2924812 PMID 7749869 Aviram M Fuhrman B November 1998 LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells role of prooxidants vs antioxidants Molecular and Cellular Biochemistry 188 1 2 149 59 doi 10 1023 A 1006841011201 PMID 9823020 S2CID 12222110 a b c d e f g h i j k l m n o p q Atherosclerosis NHLBI NIH 24 March 2022 Campbell LA Rosenfeld ME July 2015 Infection and Atherosclerosis Development Arch Med Res 46 5 339 50 doi 10 1016 j arcmed 2015 05 006 PMC 4524506 PMID 26004263 Sinha A Feinstein MJ March 2019 Coronary Artery Disease Manifestations in HIV What How and Why The Canadian Journal of Cardiology 35 3 270 279 doi 10 1016 j cjca 2018 11 029 PMC 9532012 PMID 30825949 S2CID 73469601 Enas EA Kuruvila A Khanna P Pitchumoni CS Mohan V October 2013 Benefits amp risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians a population with the highest risk of premature coronary artery disease amp diabetes The Indian Journal of Medical Research 138 4 461 91 PMC 3868060 PMID 24434254 Indian Heart Association Why South Asians Facts Web 30 April 2015 http indianheartassociation org why indians why south asians overview Tyrrell DJ Blin MB Song J Wood SC Zhang M Beard DA Goldstein DR January 2020 Age Associated Mitochondrial Dysfunction Accelerates Atherogenesis Circulation Research 126 3 298 314 doi 10 1161 CIRCRESAHA 119 315644 PMC 7006722 PMID 31818196 Velican C Velican D March 1985 Differences in the pattern of atherosclerotic involvement between non branched regions and adjacent branching points of human coronary arteries Atherosclerosis 54 3 333 342 doi 10 1016 0021 9150 85 90126 1 PMID 3994786 Borissoff JI Spronk HM Heeneman S ten Cate H June 2009 Is thrombin a key player in the coagulation atherogenesis maze Cardiovascular Research 82 3 392 403 doi 10 1093 cvr cvp066 PMID 19228706 Borissoff JI Heeneman S Kilinc E Kassak P Van Oerle R Winckers K Govers Riemslag JW Hamulyak K Hackeng TM Daemen MJ ten Cate H Spronk HM August 2010 Early atherosclerosis exhibits an enhanced procoagulant state Circulation 122 8 821 30 doi 10 1161 CIRCULATIONAHA 109 907121 PMID 20697022 Borissoff JI Spronk HM ten Cate H May 2011 The hemostatic system as a modulator of atherosclerosis The New England Journal of Medicine 364 18 1746 60 doi 10 1056 NEJMra1011670 PMID 21542745 Food and nutrition board institute of medicine of the national academies 2005 Dietary Reference Intakes for Energy Carbohydrate Fiber Fat Fatty Acids Cholesterol Protein and Amino Acids Macronutrients National Academies Press pp 481 484 doi 10 17226 10490 ISBN 978 0 309 08525 0 Mozaffarian D Rimm EB Herrington DM November 2004 Dietary fats carbohydrate and progression of coronary atherosclerosis in postmenopausal women The American Journal of Clinical Nutrition 80 5 1175 84 doi 10 1093 ajcn 80 5 1175 PMC 1270002 PMID 15531663 Bhatt DL Topol EJ July 2002 Need to test the arterial inflammation hypothesis Circulation 106 1 136 40 doi 10 1161 01 CIR 0000021112 29409 A2 PMID 12093783 Griffin M Frazer A Johnson A Collins P Owens D Tomkin GH June 1998 Cellular cholesterol synthesis the relationship to post prandial glucose and insulin following weight loss Atherosclerosis 138 2 313 8 doi 10 1016 S0021 9150 98 00036 7 PMID 9690914 King CR Knutson KL Rathouz PJ Sidney S Liu K Lauderdale DS December 2008 Short sleep duration and incident coronary artery calcification JAMA 300 24 2859 66 doi 10 1001 jama 2008 867 PMC 2661105 PMID 19109114 Provost EB Madhloum N Int Panis L De Boever P Nawrot TS 2015 Carotid intima media thickness a marker of subclinical atherosclerosis and particulate air pollution exposure the meta analytical evidence PLOS ONE 10 5 e0127014 Bibcode 2015PLoSO 1027014P doi 10 1371 journal pone 0127014 PMC 4430520 PMID 25970426 Adar SD Sheppard L Vedal S Polak JF Sampson PD Diez Roux AV Budoff M Jacobs DR Barr RG Watson K Kaufman JD April 23 2013 Fine particulate air pollution and the progression of carotid intima medial thickness a prospective cohort study from the multi ethnic study of atherosclerosis and air pollution PLOS Medicine 10 4 e1001430 doi 10 1371 journal pmed 1001430 PMC 3637008 PMID 23637576 This early analysis from MESA suggests that higher long term PM2 5 concentrations are associated with increased IMT progression and that greater reductions in PM2 5 are related to slower IMT progression Wang CH Jeng JS Yip PK Chen CL Hsu LI Hsueh YM et al April 2002 Biological gradient between long term arsenic exposure and carotid atherosclerosis Circulation 105 15 1804 1809 doi 10 1161 01 cir 0000015862 64816 b2 PMID 11956123 S2CID 535580 Treating Hypothyroidism Reduces Atherosclerosis Risk American Family Physician 69 3 656 1 February 2004 Bale BF Doneen AL Vigerust DJ April 2017 High risk periodontal pathogens contribute to the pathogenesis of atherosclerosis Postgraduate Medical Journal 93 1098 215 220 doi 10 1136 postgradmedj 2016 134279 PMC 5520251 PMID 27899684 Food Pyramids Nutrition Source Harvard School of Public Health Archived from the original on 26 December 2007 Retrieved 2007 11 25 Staprans I Rapp JH Pan XM Hardman DA Feingold KR April 1996 Oxidized lipids in the diet accelerate the development of fatty streaks in cholesterol fed rabbits Arteriosclerosis Thrombosis and Vascular Biology 16 4 533 8 doi 10 1161 01 atv 16 4 533 PMID 8624775 Song JH Fujimoto K Miyazawa T December 2000 Polyunsaturated n 3 fatty acids susceptible to peroxidation are increased in plasma and tissue lipids of rats fed docosahexaenoic acid containing oils The Journal of Nutrition 130 12 3028 33 doi 10 1093 jn 130 12 3028 PMID 11110863 Yap SC Choo YM Hew NF Yap SF Khor HT Ong AS Goh SH December 1995 Oxidative susceptibility of low density lipoprotein from rabbits fed atherogenic diets containing coconut palm or soybean oils Lipids 30 12 1145 50 doi 10 1007 BF02536616 PMID 8614305 S2CID 3960289 Greco AV Mingrone G 1990 Serum and biliary lipid pattern in rabbits feeding a diet enriched with unsaturated fatty acids Experimental Pathology 40 1 19 33 doi 10 1016 S0232 1513 11 80281 1 PMID 2279534 Scientist 98 challenges orthodoxy on causes of heart disease medicalxpress com Mattes RD December 2005 Fat taste and lipid metabolism in humans Physiology amp Behavior 86 5 691 7 doi 10 1016 j physbeh 2005 08 058 PMID 16249011 S2CID 33916150 The rancid odor of an oxidized fat is readily detectable Dobarganes C Marquez Ruiz G March 2003 Oxidized fats in foods Current Opinion in Clinical Nutrition and Metabolic Care 6 2 157 163 doi 10 1097 00075197 200303000 00004 PMID 12589185 S2CID 21085461 Dietary Supplements Food and Drug Administration 4 February 2020 Khan Merchant N Penumetcha M Meilhac O Parthasarathy S November 2002 Oxidized fatty acids promote atherosclerosis only in the presence of dietary cholesterol in low density lipoprotein receptor knockout mice The Journal of Nutrition 132 11 3256 3262 doi 10 1093 jn 132 11 3256 PMID 12421837 Atherosclerosis The Lecturio Medical Concept Library Retrieved 2 July 2021 Schwartz CJ Valente AJ Sprague EA Kelley JL Cayatte AJ Mowery J December 1992 Atherosclerosis Potential targets for stabilization and regression Circulation 86 6 Suppl III117 23 PMID 1424045 a b Linton MF Yancey PG Davies SS Jerome WG Linton EF Song WL et al 2000 The Role of Lipids and Lipoproteins in Atherosclerosis Endotext PMID 26844337 NBK343489 Robbins CS Hilgendorf I Weber GF Theurl I Iwamoto Y Figueiredo JL Gorbatov R Sukhova GK Gerhardt LM Smyth D Zavitz CC Shikatani EA Parsons M van Rooijen N Lin HY Husain M Libby P Nahrendorf M Weissleder R Swirski FK September 2013 Local proliferation dominates lesional macrophage accumulation in atherosclerosis Nature Medicine 19 9 1166 72 doi 10 1038 nm 3258 PMC 3769444 PMID 23933982 Miller JD June 2013 Cardiovascular calcification Orbicular origins Nature Materials 12 6 476 478 Bibcode 2013NatMa 12 476M doi 10 1038 nmat3663 PMID 23695741 Glagov S Weisenberg E Zarins CK Stankunavicius R Kolettis GJ May 1987 Compensatory enlargement of human atherosclerotic coronary arteries The New England Journal of Medicine 316 22 1371 5 doi 10 1056 NEJM198705283162204 PMID 3574413 Coronary atherosclerosis the fibrous plaque with calcification www pathologyatlas ro Retrieved 2010 03 25 Janoudi A Shamoun FE Kalavakunta JK Abela GS July 2016 Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque European Heart Journal 37 25 1959 67 doi 10 1093 eurheartj ehv653 PMID 26705388 Maton A Hopkins RL McLaughlin CW Johnson S Warner MQ LaHart D et al 1993 Human Biology and Health Englewood Cliffs NJ Prentice Hall ISBN 978 0 13 981176 0 OCLC 32308337 a b What Are the Signs and Symptoms of Coronary Heart Disease www nhlbi nih gov September 29 2014 Archived from the original on 24 February 2015 Retrieved 2 July 2021 Wang J Michelitsch T Wunderlin A Mahadeva R 6 April 2009 Aging as a consequence of misrepair A novel theory of aging Nature Precedings arXiv 0904 0575 doi 10 1038 npre 2009 2988 2 S2CID 2179468 Wang Michelitsch J Michelitsch T 2015 Aging as a process of accumulation of Misrepairs arXiv 1503 07163 q bio TO Wang Michelitsch J Michelitsch TM 2015 Misrepair mechanism in the development of atherosclerotic plaques arXiv 1505 01289 q bio TO Ross R January 1999 Atherosclerosis an inflammatory disease The New England Journal of Medicine 340 2 115 26 doi 10 1056 NEJM199901143400207 PMID 9887164 Finn AV Nakano M Narula J Kolodgie FD Virmani R July 2010 Concept of vulnerable unstable plaque Arteriosclerosis Thrombosis and Vascular Biology 30 7 1282 92 doi 10 1161 ATVBAHA 108 179739 PMID 20554950 Didangelos A Simper D Monaco C Mayr M May 2009 Proteomics of acute coronary syndromes Current Atherosclerosis Reports 11 3 188 95 doi 10 1007 s11883 009 0030 x PMID 19361350 S2CID 41219190 a b Tarkin JM Dweck MR Evans NR Takx RA Brown AJ Tawakol A et al February 2016 Imaging Atherosclerosis Circulation Research 118 4 750 769 doi 10 1161 CIRCRESAHA 115 306247 PMC 4756468 PMID 26892971 Stary HC Chandler AB Dinsmore RE Fuster V Glagov S Insull W et al September 1995 A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis American Heart Association Circulation 92 5 1355 1374 doi 10 1161 01 CIR 92 5 1355 PMID 7648691 Maseri A Fuster V April 2003 Is there a vulnerable plaque Circulation 107 16 2068 71 doi 10 1161 01 CIR 0000070585 48035 D1 PMID 12719286 McGill HC McMahan CA Gidding SS March 2008 Preventing heart disease in the 21st century implications of the Pathobiological Determinants of Atherosclerosis in Youth PDAY study Circulation 117 9 1216 27 doi 10 1161 CIRCULATIONAHA 107 717033 PMID 18316498 McNeal CJ Dajani T Wilson D Cassidy Bushrow AE Dickerson JB Ory M January 2010 Hypercholesterolemia in youth opportunities and obstacles to prevent premature atherosclerotic cardiovascular disease Current Atherosclerosis Reports 12 1 20 8 doi 10 1007 s11883 009 0072 0 PMID 20425267 S2CID 37833889 Rice BH 2014 Dairy and Cardiovascular Disease A Review of Recent Observational Research Current Nutrition Reports 3 2 130 138 doi 10 1007 s13668 014 0076 4 PMC 4006120 PMID 24818071 Kratz M Baars T Guyenet S February 2013 The relationship between high fat dairy consumption and obesity cardiovascular and metabolic disease European Journal of Nutrition 52 1 1 24 doi 10 1007 s00394 012 0418 1 PMID 22810464 S2CID 1360916 Wang X Ouyang Y Liu J Zhu M Zhao G Bao W Hu FB July 2014 Fruit and vegetable consumption and mortality from all causes cardiovascular disease and cancer systematic review and dose response meta analysis of prospective cohort studies BMJ 349 g4490 doi 10 1136 bmj g4490 PMC 4115152 PMID 25073782 Walker C Reamy BV April 2009 Diets for cardiovascular disease prevention what is the evidence American Family Physician 79 7 571 8 PMID 19378874 Nordmann AJ Suter Zimmermann K Bucher HC Shai I Tuttle KR Estruch R Briel M September 2011 Meta analysis comparing Mediterranean to low fat diets for modification of cardiovascular risk factors The American Journal of Medicine 124 9 841 51 e2 doi 10 1016 j amjmed 2011 04 024 PMID 21854893 Paul P Williams B eds 2009 Cardiovascular Circulatory and Hematologic Function Brunner amp Suddarth s Textbook of Canadian Medical surgical Nursing Lippincott Williams amp Wilkins pp 730 1047 ISBN 978 0 7817 9989 8 a b Fonarow G 2003 Aggressive treatment of atherosclerosis The time is now Cleve Clin J Med 70 5 431 434 doi 10 3949 ccjm 70 5 431 PMID 12785316 Ambrose JA Barua RS May 2004 The pathophysiology of cigarette smoking and cardiovascular disease an update Journal of the American College of Cardiology 43 10 1731 7 doi 10 1016 j jacc 2003 12 047 PMID 15145091 Pigozzi F Rizzo M Fagnani F Parisi A Spataro A Casasco M Borrione P June 2011 Endothelial dys function the target of physical exercise for prevention and treatment of cardiovascular disease The Journal of Sports Medicine and Physical Fitness 51 2 260 267 PMID 21681161 Gupta Keshav Kumar Ali Shair Sanghera Ranjodh Singh June 2019 Pharmacological Options in Atherosclerosis A Review of the Existing Evidence Cardiology and Therapy 8 1 5 20 doi 10 1007 s40119 018 0123 0 ISSN 2193 8261 PMC 6525235 PMID 30543029 Koh KK Han SH Oh PC Shin EK Quon MJ April 2010 Combination therapy for treatment or prevention of atherosclerosis focus on the lipid RAAS interaction Atherosclerosis 209 2 307 13 doi 10 1016 j atherosclerosis 2009 09 007 PMC 2962413 PMID 19800624 Taylor F Huffman MD Macedo AF Moore TH Burke M Davey Smith G et al January 2013 Statins for the primary prevention of cardiovascular disease The Cochrane Database of Systematic Reviews 1 1 CD004816 doi 10 1002 14651858 CD004816 pub5 PMC 6481400 PMID 23440795 Virani SS Smith SC Stone NJ Grundy SM April 2020 Secondary Prevention for Atherosclerotic Cardiovascular Disease Comparing Recent US and European Guidelines on Dyslipidemia Circulation 141 14 1121 1123 doi 10 1161 CIRCULATIONAHA 119 044282 PMID 32250694 Grundy SM Stone NJ Bailey AL Beam C Birtcher KK Blumenthal RS et al June 2019 2018 AHA ACC AACVPR AAPA ABC ACPM ADA AGS APhA ASPC NLA PCNA Guideline on the Management of Blood Cholesterol A Report of the American College of Cardiology American Heart Association Task Force on Clinical Practice Guidelines Journal of the American College of Cardiology 73 24 e285 e350 doi 10 1016 j jacc 2018 11 003 hdl 20 500 12749 1738 PMID 30423393 Nanna MG Wang TY Xiang Q Goldberg AC Robinson JG Roger VL et al August 2019 Sex Differences in the Use of Statins in Community Practice Circulation Cardiovascular Quality and Outcomes 12 8 e005562 doi 10 1161 CIRCOUTCOMES 118 005562 PMC 6903404 PMID 31416347 Lee MT Mahtta D Ramsey DJ Liu J Misra A Nasir K et al July 2021 Sex Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease JAMA Cardiology 6 7 782 790 doi 10 1001 jamacardio 2021 0683 PMC 8060887 PMID 33881448 Vos E Rose CP November 2005 Questioning the benefits of statins CMAJ 173 10 1207 author reply 1210 doi 10 1503 cmaj 1050120 PMC 1277053 PMID 16275976 Zhao DF Edelman JJ Seco M Bannon PG Wilson MK Byrom MJ Thourani V Lamy A Taggart DP Puskas JD Vallely MP February 2017 Coronary Artery Bypass Grafting With and Without Manipulation of the Ascending Aorta A Network Meta Analysis Journal of the American College of Cardiology 69 8 924 936 doi 10 1016 j jacc 2016 11 071 PMID 28231944 Vlasschaert C Goss CJ Pilkey NG McKeown S Holden RM September 2020 Vitamin K Supplementation for the Prevention of Cardiovascular Disease Where Is the Evidence A Systematic Review of Controlled Trials Nutrients 12 10 2909 doi 10 3390 nu12102909 PMC 7598164 PMID 32977548 Price PA Faus SA Williamson MK February 2000 Warfarin induced artery calcification is accelerated by growth and vitamin D Arteriosclerosis Thrombosis and Vascular Biology 20 2 317 327 doi 10 1161 01 ATV 20 2 317 PMID 10669626 Geleijnse JM Vermeer C Grobbee DE Schurgers LJ Knapen MH van der Meer IM et al November 2004 Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease the Rotterdam Study The Journal of Nutrition 134 11 3100 3105 doi 10 1093 jn 134 11 3100 hdl 1765 10366 PMID 15514282 Vitamin K Linus Pauling Institute at Oregon State University Archived from the original on 7 April 2010 Retrieved 2010 03 25 Kong BS Cho YH Lee EJ 2014 G protein coupled estrogen receptor 1 is involved in the protective effect of protocatechuic aldehyde against endothelial dysfunction PLOS ONE 9 11 e113242 Bibcode 2014PLoSO 9k3242K doi 10 1371 journal pone 0113242 PMC 4239058 PMID 25411835 Kong BS Im SJ Lee YJ Cho YH Do YR Byun JW et al 2016 Vasculoprotective Effects of 3 Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation PLOS ONE 11 3 e0149394 Bibcode 2016PLoSO 1149394K doi 10 1371 journal pone 0149394 PMC 4803227 PMID 27002821 The top 10 causes of death www who int Retrieved 2020 01 26 Kumar Vinay Abbas Abul K Fausto Nelson amp Mitchell Richard N 2007 Robbins Basic Pathology 8th ed Saunders Elsevier pp 348 351 ISBN 978 1 4160 2973 1 Strong J P McGill H C 1969 05 06 The pediatric aspects of atherosclerosis Journal of Atherosclerosis Research 9 3 251 265 doi 10 1016 S0368 1319 69 80020 7 ISSN 0368 1319 PMID 5346899 Zieske Arthur W Malcom Gray T Strong Jack P January 2002 Natural history and risk factors of atherosclerosis in children and youth The PDAY study Pediatric Pathology amp Molecular Medicine 21 2 213 237 doi 10 1080 pdp 21 2 213 237 ISSN 1522 7952 PMID 11942537 S2CID 218896145 Enos William F 1953 07 18 Coronary Disease Among United States Soldiers Killed in Action in Korea Journal of the American Medical Association 152 12 1090 1093 doi 10 1001 jama 1953 03690120006002 ISSN 0002 9955 PMID 13052433 Stopping Heart Disease in Childhood NutritionFacts org 15 July 2014 Retrieved 2022 12 08 Wilson Don P 2000 Feingold Kenneth R Anawalt Bradley Boyce Alison Chrousos George eds Is Atherosclerosis a Pediatric Disease Endotext South Dartmouth MA MDText com Inc PMID 27809437 retrieved 2022 12 08 Strong Jack P Malcom Gray T Newman William P Oalmann Margaret C June 1992 Early Lesions of Atherosclerosis in Childhood and Youth Natural History and Risk Factors Journal of the American College of Nutrition 11 sup1 51S 54S doi 10 1080 07315724 1992 10737984 ISSN 0731 5724 PMID 1619200 Mendis Shanthi Nordet P Fernandez Britto J E Sternby N 2005 03 01 Atherosclerosis in children and young adults An overview of the World Health Organization and International Society and Federation of Cardiology study on Pathobiological Determinants of Atherosclerosis in Youth study 1985 1995 Global Heart 1 1 3 doi 10 1016 j precon 2005 02 010 ISSN 2211 8179 Atherogenic Merriam Webster Dictionary Pfuntner A Wier LM Steiner C December 2013 Costs for Hospital Stays in the United States 2011 HCUP Statistical Brief 168 Rockville MD Agency for Healthcare Research and Quality PMID 24455786 Barter PJ Caulfield M Eriksson M Grundy SM Kastelein JJ Komajda M Lopez Sendon J Mosca L Tardif JC Waters DD Shear CL Revkin JH Buhr KA Fisher MR Tall AR Brewer B November 2007 Effects of torcetrapib in patients at high risk for coronary events The New England Journal of Medicine 357 21 2109 22 doi 10 1056 NEJMoa0706628 PMID 17984165 Nilsson J Hansson GK Shah PK January 2005 Immunomodulation of atherosclerosis implications for vaccine development Arteriosclerosis Thrombosis and Vascular Biology 25 1 18 28 doi 10 1161 01 ATV 0000149142 42590 a2 PMID 15514204 Spiteller G November 2005 The relation of lipid peroxidation processes with atherogenesis a new theory on atherogenesis Molecular Nutrition amp Food Research 49 11 999 1013 doi 10 1002 mnfr 200500055 PMID 16270286 Berbee JF Mol IM Milne GL Pollock E Hoeke G Lutjohann D Monaco C Rensen PC van der Ploeg LH Shchepinov MS September 2017 Deuterium reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia Atherosclerosis 264 100 107 doi 10 1016 j atherosclerosis 2017 06 916 PMID 28655430 S2CID 21408028 Tsikas D September 2017 Combating atherosclerosis with heavy PUFAs Deuteron not proton is the first Atherosclerosis 264 79 82 doi 10 1016 j atherosclerosis 2017 07 018 PMID 28756876 a b Chen WJ Yin K Zhao GJ Fu YC Tang CK June 2012 The magic and mystery of microRNA 27 in atherosclerosis Atherosclerosis 222 2 314 23 doi 10 1016 j atherosclerosis 2012 01 020 PMID 22307089 Sacco J Adeli K June 2012 MicroRNAs emerging roles in lipid and lipoprotein metabolism Current Opinion in Lipidology 23 3 220 5 doi 10 1097 MOL 0b013e3283534c9f PMID 22488426 S2CID 23814795 Bommer GT MacDougald OA March 2011 Regulation of lipid homeostasis by the bifunctional SREBF2 miR33a locus Cell Metabolism 13 3 241 7 doi 10 1016 j cmet 2011 02 004 PMC 3062104 PMID 21356514 Rayner KJ Sheedy FJ Esau CC Hussain FN Temel RE Parathath S van Gils JM Rayner AJ Chang AN Suarez Y Fernandez Hernando C Fisher EA Moore KJ July 2011 Antagonism of miR 33 in mice promotes reverse cholesterol transport and regression of atherosclerosis The Journal of Clinical Investigation 121 7 2921 31 doi 10 1172 JCI57275 PMC 3223840 PMID 21646721 Iwakiri Y March 2012 A role of miR 33 for cell cycle progression and cell proliferation Cell Cycle 11 6 1057 8 doi 10 4161 cc 11 6 19744 PMID 22395363 Singaraja RR Stahmer B Brundert M Merkel M Heeren J Bissada N Kang M Timmins JM Ramakrishnan R Parks JS Hayden MR Rinninger F August 2006 Hepatic ATP binding cassette transporter A1 is a key molecule in high density lipoprotein cholesteryl ester metabolism in mice Arteriosclerosis Thrombosis and Vascular Biology 26 8 1821 7 doi 10 1161 01 ATV 0000229219 13757 a2 PMID 16728652 Zimmer S Grebe A Bakke SS Bode N Halvorsen B Ulas T Skjelland M De Nardo D Labzin LI Kerksiek A Hempel C Heneka MT Hawxhurst V Fitzgerald ML Trebicka J Bjorkhem I Gustafsson JA Westerterp M Tall AR Wright SD Espevik T Schultze JL Nickenig G Lutjohann D Latz E April 2016 Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming Science Translational Medicine 8 333 333ra50 doi 10 1126 scitranslmed aad6100 PMC 4878149 PMID 27053774 Lay summary in Hesman Saey T April 8 2016 A sugar can melt away cholesterol Science News org Wu H Roks AJ February 2014 Genomic instability and vascular aging a focus on nucleotide excision repair Trends in Cardiovascular Medicine 24 2 61 8 doi 10 1016 j tcm 2013 06 005 PMID 23953979 a b Bautista Nino PK Portilla Fernandez E Vaughan DE Danser AH Roks AJ May 2016 DNA Damage A Main Determinant of Vascular Aging International Journal of Molecular Sciences 17 5 748 doi 10 3390 ijms17050748 PMC 4881569 PMID 27213333 Shah AV Bennett MR December 2017 DNA damage dependent mechanisms of ageing and disease in the macro and microvasculature European Journal of Pharmacology 816 116 128 doi 10 1016 j ejphar 2017 03 050 PMID 28347738 S2CID 1034518 a b Martinet W Knaapen MW De Meyer GR Herman AG Kockx MM August 2002 Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques Circulation 106 8 927 32 doi 10 1161 01 cir 0000026393 47805 21 PMID 12186795 Ishida T Ishida M Tashiro S Yoshizumi M Kihara Y 2014 Role of DNA damage in cardiovascular disease Circulation Journal 78 1 42 50 doi 10 1253 circj CJ 13 1194 PMID 24334614 a b Barrington WT Lusis AJ December 2017 Atherosclerosis Association between the gut microbiome and atherosclerosis Nature Reviews Cardiology 14 12 699 700 doi 10 1038 nrcardio 2017 169 PMC 5815826 PMID 29099096 Jie Z Xia H Zhong SL Feng Q Li S Liang S et al October 2017 The gut microbiome in atherosclerotic cardiovascular disease Nature Communications 8 1 845 Bibcode 2017NatCo 8 845J doi 10 1038 s41467 017 00900 1 PMC 5635030 PMID 29018189 a b c Harman JL Jorgensen HF October 2019 The role of smooth muscle cells in plaque stability Therapeutic targeting potential British Journal of Pharmacology 176 19 3741 3753 doi 10 1111 bph 14779 PMC 6780045 PMID 31254285 Bennett MR Sinha S Owens GK February 2016 Vascular Smooth Muscle Cells in Atherosclerosis Circulation Research 118 4 692 702 doi 10 1161 CIRCRESAHA 115 306361 PMC 4762053 PMID 26892967 Gomez D Shankman LS Nguyen AT Owens GK February 2013 Detection of histone modifications at specific gene loci in single cells in histological sections Nature Methods 10 2 171 177 doi 10 1038 nmeth 2332 PMC 3560316 PMID 23314172 a b Wang Y Dubland JA Allahverdian S Asonye E Sahin B Jaw JE et al May 2019 Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE Apolipoprotein E Deficient Mouse Atherosclerosis Arteriosclerosis Thrombosis and Vascular Biology 39 5 876 887 doi 10 1161 ATVBAHA 119 312434 PMC 6482082 PMID 30786740 a b Chappell J Harman JL Narasimhan VM Yu H Foote K Simons BD et al December 2016 Extensive Proliferation of a Subset of Differentiated yet Plastic Medial Vascular Smooth Muscle Cells Contributes to Neointimal Formation in Mouse Injury and Atherosclerosis Models Circulation Research 119 12 1313 1323 doi 10 1161 CIRCRESAHA 116 309799 PMC 5149073 PMID 27682618 Durham AL Speer MY Scatena M Giachelli CM Shanahan CM March 2018 Role of smooth muscle cells in vascular calcification implications in atherosclerosis and arterial stiffness Cardiovascular Research 114 4 590 600 doi 10 1093 cvr cvy010 PMC 5852633 PMID 29514202 Basatemur GL Jorgensen HF Clarke MC Bennett MR Mallat Z December 2019 Vascular smooth muscle cells in atherosclerosis Nature Reviews Cardiology 16 12 727 744 doi 10 1038 s41569 019 0227 9 PMID 31243391 S2CID 195657448 External links edit nbsp Wikimedia Commons has media related to Atherosclerosis nbsp Quotations related to Atherosclerosis at Wikiquote Atherosclerosis at Curlie Atherosclerosis pathophysiology stages and types Retrieved from https en wikipedia org w index php title Atherosclerosis amp oldid 1194317658, wikipedia, wiki, book, books, library,

article

, read, download, free, free download, mp3, video, mp4, 3gp, jpg, jpeg, gif, png, picture, music, song, movie, book, game, games.